These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Maryland
|
|
20-2287134
|
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
|
incorporation or organization)
|
|
Identification No.)
|
|
|
|
|
|
717 Fifth Avenue, New York, New York 10022
|
||
|
(Address of principal executive offices) (Zip Code)
|
||
|
|
|
|
|
(212) 621-3210
|
||
|
(Registrant's telephone number, including area code)
|
||
|
Large accelerated filer
|
¨
|
|
Accelerated filer
|
þ
|
|
Non-accelerated filer
|
¨
|
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
|
|
|
Emerging growth company
|
¨
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
|
||||
|
|
|
PAGE
|
|
PART I
|
|
|
|
Item 1:
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2:
|
||
|
|
|
|
|
Item 3:
|
||
|
|
|
|
|
Item 4:
|
||
|
|
|
|
|
PART II
|
|
|
|
|
|
|
|
Item 1:
|
||
|
|
|
|
|
Item 1A:
|
||
|
|
|
|
|
Item 6:
|
||
|
|
|
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
|
(unaudited)
|
|
|
||||
|
ASSETS
(1)
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
61,500
|
|
|
$
|
181,490
|
|
|
Restricted cash
|
546
|
|
|
22,874
|
|
||
|
Accrued interest receivable
|
6,945
|
|
|
6,859
|
|
||
|
CRE loans, net of allowances of $4,529 and $5,328
|
1,376,999
|
|
|
1,284,822
|
|
||
|
Investment securities available-for-sale
|
250,746
|
|
|
211,737
|
|
||
|
Investment securities, trading
|
164
|
|
|
178
|
|
||
|
Loans held for sale
|
—
|
|
|
13
|
|
||
|
Principal paydowns receivable
|
20
|
|
|
76,129
|
|
||
|
Investments in unconsolidated entities
|
6,439
|
|
|
12,051
|
|
||
|
Derivatives, at fair value
|
1,751
|
|
|
602
|
|
||
|
Direct financing leases, net of allowances of $735
|
89
|
|
|
151
|
|
||
|
Other assets
|
6,981
|
|
|
7,451
|
|
||
|
Assets held for sale (amounts include $57,341 and $61,841 of legacy CRE loans held for sale in continuing operations, see Note 21)
|
77,621
|
|
|
107,718
|
|
||
|
Total assets
|
$
|
1,789,801
|
|
|
$
|
1,912,075
|
|
|
LIABILITIES
(2)
|
|
|
|
|
|
||
|
Accounts payable and other liabilities
|
$
|
6,654
|
|
|
$
|
5,153
|
|
|
Management fee payable
|
938
|
|
|
1,035
|
|
||
|
Accrued interest payable
|
3,244
|
|
|
4,387
|
|
||
|
Borrowings
|
1,222,386
|
|
|
1,163,485
|
|
||
|
Distributions payable
|
3,308
|
|
|
5,581
|
|
||
|
Preferred stock redemption liability
|
—
|
|
|
50,000
|
|
||
|
Derivatives, at fair value
|
—
|
|
|
76
|
|
||
|
Accrued tax liability
|
209
|
|
|
540
|
|
||
|
Liabilities held for sale (see Note 21)
|
2,883
|
|
|
10,342
|
|
||
|
Total liabilities
|
1,239,622
|
|
|
1,240,599
|
|
||
|
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
||
|
Preferred stock, par value $0.001: 10,000,000 shares authorized 8.25% Series B Cumulative Redeemable Preferred Stock, liquidation preference $25.00 per share; 0 and 4,613,596 shares issued and outstanding
|
—
|
|
|
5
|
|
||
|
Preferred stock, par value $0.001: 10,000,000 shares authorized 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock, liquidation preference $25.00 per share; 4,800,000 and 4,800,000 shares issued and outstanding
|
5
|
|
|
5
|
|
||
|
Common stock, par value $0.001: 125,000,000 shares authorized; 31,650,417 and 31,429,892 shares issued and outstanding (including 465,808 and 483,073 unvested restricted shares)
|
32
|
|
|
31
|
|
||
|
Additional paid-in capital
|
1,080,927
|
|
|
1,187,911
|
|
||
|
Accumulated other comprehensive income
|
1,154
|
|
|
1,297
|
|
||
|
Distributions in excess of earnings
|
(531,939
|
)
|
|
(517,773
|
)
|
||
|
Total stockholders' equity
|
550,179
|
|
|
671,476
|
|
||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
1,789,801
|
|
|
$
|
1,912,075
|
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
|
(unaudited)
|
|
|
||||
|
(1) Assets of consolidated variable interest entities ("VIEs") included in total assets above:
|
|
|
|
||||
|
Restricted cash
|
$
|
513
|
|
|
$
|
20,846
|
|
|
Accrued interest receivable
|
2,728
|
|
|
3,347
|
|
||
|
CRE loans, pledged as collateral and net of allowances of $844 and $1,330
|
571,640
|
|
|
603,110
|
|
||
|
Loans held for sale
|
—
|
|
|
13
|
|
||
|
Principal paydowns receivable
|
20
|
|
|
72,207
|
|
||
|
Other assets
|
188
|
|
|
73
|
|
||
|
Total assets of consolidated VIEs
|
$
|
575,089
|
|
|
$
|
699,596
|
|
|
|
|
|
|
||||
|
(2) Liabilities of consolidated VIEs included in total liabilities above:
|
|
|
|
||||
|
Accounts payable and other liabilities
|
$
|
65
|
|
|
$
|
96
|
|
|
Accrued interest payable
|
412
|
|
|
592
|
|
||
|
Borrowings
|
298,970
|
|
|
416,655
|
|
||
|
Total liabilities of consolidated VIEs
|
$
|
299,447
|
|
|
$
|
417,343
|
|
|
|
For the Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
REVENUES
|
|
|
|
||||
|
Interest income:
|
|
|
|
||||
|
CRE loans
|
$
|
22,383
|
|
|
$
|
21,533
|
|
|
Securities
|
3,456
|
|
|
2,308
|
|
||
|
Other
|
118
|
|
|
1,630
|
|
||
|
Total interest income
|
25,957
|
|
|
25,471
|
|
||
|
Interest expense
|
14,384
|
|
|
14,254
|
|
||
|
Net interest income
|
11,573
|
|
|
11,217
|
|
||
|
Other (expense) revenue
|
(95
|
)
|
|
928
|
|
||
|
Total revenues
|
11,478
|
|
|
12,145
|
|
||
|
OPERATING EXPENSES
|
|
|
|
|
|
||
|
Management fees
|
2,813
|
|
|
2,680
|
|
||
|
Equity compensation
|
967
|
|
|
788
|
|
||
|
General and administrative
|
3,060
|
|
|
3,863
|
|
||
|
Depreciation and amortization
|
13
|
|
|
68
|
|
||
|
Impairment losses
|
—
|
|
|
177
|
|
||
|
(Recovery of) provision for loan and lease losses, net
|
(799
|
)
|
|
999
|
|
||
|
Total operating expenses
|
6,054
|
|
|
8,575
|
|
||
|
|
|
|
|
||||
|
|
5,424
|
|
|
3,570
|
|
||
|
OTHER INCOME (EXPENSE)
|
|
|
|
|
|
||
|
Equity in (losses) earnings of unconsolidated entities
|
(292
|
)
|
|
361
|
|
||
|
Net realized and unrealized (loss) gain on investment securities available-for-sale and loans and derivatives
|
(642
|
)
|
|
7,606
|
|
||
|
Net realized and unrealized loss on investment securities, trading
|
(5
|
)
|
|
(911
|
)
|
||
|
Fair value adjustments on financial assets held for sale
|
(4,665
|
)
|
|
(21
|
)
|
||
|
Other income
|
11
|
|
|
68
|
|
||
|
Total other (expense) income
|
(5,593
|
)
|
|
7,103
|
|
||
|
|
|
|
|
||||
|
(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE TAXES
|
(169
|
)
|
|
10,673
|
|
||
|
Income tax benefit (expense)
|
32
|
|
|
(1,499
|
)
|
||
|
NET (LOSS) INCOME FROM CONTINUING OPERATIONS
|
(137
|
)
|
|
9,174
|
|
||
|
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS, NET OF TAX
|
247
|
|
|
(561
|
)
|
||
|
NET INCOME
|
110
|
|
|
8,613
|
|
||
|
Net income allocated to preferred shares
|
(5,210
|
)
|
|
(6,014
|
)
|
||
|
Consideration paid in excess of carrying value of preferred shares
|
(7,482
|
)
|
|
—
|
|
||
|
Net loss allocable to non-controlling interest, net of taxes
|
—
|
|
|
101
|
|
||
|
NET (LOSS) INCOME ALLOCABLE TO COMMON SHARES
|
$
|
(12,582
|
)
|
|
$
|
2,700
|
|
|
NET (LOSS) INCOME PER COMMON SHARE - BASIC:
|
|
|
|
||||
|
CONTINUING OPERATIONS
|
$
|
(0.41
|
)
|
|
$
|
0.11
|
|
|
DISCONTINUED OPERATIONS
|
$
|
0.01
|
|
|
$
|
(0.02
|
)
|
|
TOTAL NET (LOSS) INCOME PER COMMON SHARE - BASIC
|
$
|
(0.40
|
)
|
|
$
|
0.09
|
|
|
NET (LOSS) INCOME PER COMMON SHARE - DILUTED:
|
|
|
|
||||
|
CONTINUING OPERATIONS
|
$
|
(0.41
|
)
|
|
$
|
0.11
|
|
|
DISCONTINUED OPERATIONS
|
$
|
0.01
|
|
|
$
|
(0.02
|
)
|
|
TOTAL NET (LOSS) INCOME PER COMMON SHARE - DILUTED
|
$
|
(0.40
|
)
|
|
$
|
0.09
|
|
|
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC
|
31,111,315
|
|
|
30,752,006
|
|
||
|
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED
|
31,111,315
|
|
|
30,914,148
|
|
||
|
|
For the Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Net income
|
$
|
110
|
|
|
$
|
8,613
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
||
|
Reclassification adjustments for realized losses on investment securities available-for-sale included in net income
|
217
|
|
|
—
|
|
||
|
Unrealized (losses) gains on investment securities available-for-sale, net
|
(1,509
|
)
|
|
134
|
|
||
|
Reclassification adjustments associated with unrealized losses from interest rate hedges included in net income
|
—
|
|
|
18
|
|
||
|
Unrealized gains on derivatives, net
|
1,149
|
|
|
—
|
|
||
|
Total other comprehensive (loss) income
|
(143
|
)
|
|
152
|
|
||
|
Comprehensive (loss) income before allocation to non-controlling interests and preferred shares
|
(33
|
)
|
|
8,765
|
|
||
|
Net loss allocable to non-controlling interest
|
—
|
|
|
101
|
|
||
|
Net income allocated to preferred shares
|
(5,210
|
)
|
|
(6,014
|
)
|
||
|
Consideration paid in excess of carrying value of preferred shares
|
(7,482
|
)
|
|
—
|
|
||
|
Comprehensive (loss) income allocable to common shares
|
$
|
(12,725
|
)
|
|
$
|
2,852
|
|
|
|
Common Stock
|
|
Series B Preferred Stock
|
|
Series C Preferred Stock
|
|
Additional Paid-In Capital
|
|
Accumulated Other Comprehensive Income
|
|
Retained Earnings
|
|
Distributions in Excess of Earnings
|
|
Total Stockholders' Equity
|
|||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Balance, January 1, 2018
|
31,429,892
|
|
|
$
|
31
|
|
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
1,187,911
|
|
|
$
|
1,297
|
|
|
$
|
—
|
|
|
$
|
(517,773
|
)
|
|
$
|
671,476
|
|
|
Offering costs
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
Stock based compensation
|
229,384
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
||||||||
|
Amortization of stock based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
967
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
967
|
|
||||||||
|
Retirement of common stock
|
(7,134
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(70
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(70
|
)
|
||||||||
|
Forfeiture of unvested stock
|
(1,725
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
110
|
|
|
—
|
|
|
110
|
|
||||||||
|
Distributions on preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,210
|
)
|
|
—
|
|
|
(5,210
|
)
|
||||||||
|
Preferred stock redemption
|
—
|
|
|
—
|
|
|
(5
|
)
|
|
—
|
|
|
(107,881
|
)
|
|
—
|
|
|
(7,482
|
)
|
|
—
|
|
|
(115,368
|
)
|
||||||||
|
Securities available-for-sale, fair value adjustment, net
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,292
|
)
|
|
—
|
|
|
—
|
|
|
(1,292
|
)
|
||||||||
|
Designated derivatives, fair value adjustment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,149
|
|
|
—
|
|
|
—
|
|
|
1,149
|
|
||||||||
|
Distributions on common stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,582
|
|
|
(14,166
|
)
|
|
(1,584
|
)
|
||||||||
|
Balance, March 31, 2018
|
31,650,417
|
|
|
$
|
32
|
|
|
$
|
—
|
|
|
$
|
5
|
|
|
$
|
1,080,927
|
|
|
$
|
1,154
|
|
|
$
|
—
|
|
|
$
|
(531,939
|
)
|
|
$
|
550,179
|
|
|
|
For the Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
||||
|
Net income
|
$
|
110
|
|
|
$
|
8,613
|
|
|
Net (income) loss from discontinued operations, net of tax
|
(247
|
)
|
|
561
|
|
||
|
Net (loss) income from continuing operations
|
(137
|
)
|
|
9,174
|
|
||
|
Adjustments to reconcile net (loss) income from continuing operations to net cash provided by continuing operating activities:
|
|
|
|
||||
|
(Recovery of) provision for loan and lease losses, net
|
(799
|
)
|
|
999
|
|
||
|
Depreciation, amortization and accretion
|
916
|
|
|
(349
|
)
|
||
|
Amortization of stock based compensation
|
967
|
|
|
788
|
|
||
|
Sale of and principal payments on syndicated corporate loans held for sale
|
41
|
|
|
1,076
|
|
||
|
Sale of and principal payments on investment securities, trading, net
|
—
|
|
|
4,493
|
|
||
|
Net realized and unrealized loss on investment securities, trading
|
5
|
|
|
911
|
|
||
|
Net realized and unrealized loss (gain) on investment securities available-for-sale and loans and derivatives
|
642
|
|
|
(7,606
|
)
|
||
|
Fair value adjustments on financial assets held for sale
|
4,665
|
|
|
21
|
|
||
|
Impairment losses
|
—
|
|
|
177
|
|
||
|
Equity in losses (earnings) of unconsolidated entities
|
292
|
|
|
(361
|
)
|
||
|
Return on investment from investments in unconsolidated entities
|
—
|
|
|
6,292
|
|
||
|
Changes in operating assets and liabilities
|
5,119
|
|
|
1,465
|
|
||
|
Net cash provided by continuing operating activities
|
11,711
|
|
|
17,080
|
|
||
|
Net cash (used in) provided by discontinued operating activities
|
(105
|
)
|
|
47,205
|
|
||
|
Net cash provided by operating activities
|
11,606
|
|
|
64,285
|
|
||
|
|
|
|
|
||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
||
|
Origination and purchase of loans
|
(142,124
|
)
|
|
(119,240
|
)
|
||
|
Principal payments received on loans and leases
|
127,456
|
|
|
116,159
|
|
||
|
Proceeds from sale of loans
|
—
|
|
|
21,250
|
|
||
|
Purchase of investment securities available-for-sale
|
(43,284
|
)
|
|
—
|
|
||
|
Principal payments on investment securities available-for-sale
|
3,572
|
|
|
7,519
|
|
||
|
Proceeds from sale of investment securities available-for-sale
|
59
|
|
|
9,422
|
|
||
|
Return of capital from investments in unconsolidated entities
|
5,376
|
|
|
7,703
|
|
||
|
Settlement of derivative instruments
|
(46
|
)
|
|
106
|
|
||
|
Net cash (used in) provided by continuing investing activities
|
(48,991
|
)
|
|
42,919
|
|
||
|
Net cash provided by discontinued investing activities
|
12,730
|
|
|
4,902
|
|
||
|
Net cash (used in) provided by investing activities
|
(36,261
|
)
|
|
47,821
|
|
||
|
|
|
|
|
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
||||
|
Repurchase of common stock
|
—
|
|
|
(74
|
)
|
||
|
Retirement of common stock
|
(56
|
)
|
|
—
|
|
||
|
Repurchase of preferred stock
|
(165,340
|
)
|
|
—
|
|
||
|
Net proceeds from repurchase agreements
|
175,042
|
|
|
83,513
|
|
||
|
Payments on borrowings:
|
|
|
|
|
|||
|
Securitizations
|
(118,243
|
)
|
|
(100,542
|
)
|
||
|
Distributions paid on preferred stock
|
(7,495
|
)
|
|
(6,014
|
)
|
||
|
Distributions paid on common stock
|
(1,571
|
)
|
|
(1,550
|
)
|
||
|
Net cash used in continuing financing activities
|
(117,663
|
)
|
|
(24,667
|
)
|
||
|
Net cash used in discontinued financing activities
|
—
|
|
|
(44,233
|
)
|
||
|
Net cash used in financing activities
|
(117,663
|
)
|
|
(68,900
|
)
|
||
|
|
|
|
|
||||
|
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
|
(142,318
|
)
|
|
43,206
|
|
||
|
|
For the Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD
|
204,364
|
|
|
119,425
|
|
||
|
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD
|
$
|
62,046
|
|
|
$
|
162,631
|
|
|
SUPPLEMENTAL DISCLOSURE:
|
|
|
|
|
|
||
|
Interest expense paid in cash
|
$
|
13,266
|
|
|
$
|
12,648
|
|
|
Income taxes paid in cash
|
$
|
—
|
|
|
$
|
515
|
|
|
•
|
RCC Real Estate, Inc. ("RCC Real Estate"), a wholly-owned subsidiary, holds CRE loans, CRE-related securities and historically has held direct investments in real estate. RCC Real Estate owns
100.0%
of the equity of the following VIEs:
|
|
◦
|
Resource Capital Corp. CRE Notes 2013, Ltd. ("RCC CRE Notes 2013") and Resource Capital Corp. 2014-CRE2, Ltd. ("RCC 2014-CRE2") were established to complete CRE securitization issuances secured by a portfolio of CRE loans. In December 2016 and August 2017, RCC CRE Notes 2013 and RCC 2014-CRE2, respectively, were liquidated and, as a result, the remaining assets were returned to the Company in exchange for the Company's preference shares and equity notes in the securitizations.
|
|
◦
|
Resource Capital Corp. 2015-CRE3, Ltd. ("RCC 2015-CRE3"), Resource Capital Corp. 2015-CRE4, Ltd. ("RCC 2015-CRE4") and Resource Capital Corp. 2017-CRE5, Ltd. ("RCC 2017-CRE5") were each established to complete CRE securitization issuances secured by a separate portfolio of loans.
|
|
•
|
RCC Commercial, Inc. ("RCC Commercial"), a wholly-owned subsidiary, holds a
29.6%
investment in NEW NP, LLC ("New NP, LLC"), which holds one directly originated middle market loan and historically held syndicated corporate loan investments. New NP, LLC is reported in discontinued operations, see
Note 21
for further discussion. RCC Commercial also owns
100.0%
of Apidos CDO III, Ltd. ("Apidos CDO III"). Apidos CDO III, a taxable REIT subsidiary ("TRS"), was established to complete a collateralized debt obligation ("CDO") issuance secured by a portfolio of syndicated corporate loans and asset-backed securities ("ABS"). In June 2015, the Company liquidated Apidos CDO III and, as a result, all of the assets were sold.
|
|
•
|
RCC Commercial II, Inc. ("Commercial II"), a wholly-owned subsidiary, invests in structured notes and subordinated notes of foreign, syndicated corporate loan collateralized loan obligation ("CLO") vehicles. Commercial II also owns equity in the following VIEs:
|
|
◦
|
Commercial II owns
100.0%
of the equity of Apidos Cinco CDO ("Apidos Cinco"),
a TRS that was established to complete a CDO issuance secured by a portfolio of syndicated corporate loans, ABS and corporate bonds. In November 2016, the Company liquidated and sold substantially all of Apidos Cinco's assets. The remaining assets were consolidated by the Company upon liquidation and are marked at fair value.
|
|
◦
|
Commercial II owns
68.3%
of the equity of Whitney CLO I, Ltd. ("Whitney CLO I"), a TRS that holds residual assets following a September 2013 liquidation.
|
|
•
|
RCC Commercial III, Inc. ("Commercial III"), a wholly-owned subsidiary, holds investments in syndicated corporate loan investments. Commercial III owns
90.0%
of the equity of Apidos CDO I, LTD. ("Apidos CDO I"). Apidos CDO I, a TRS, was established to complete a CDO issuance secured by a portfolio of syndicated corporate loans and ABS. In October 2014, the Company liquidated Apidos CDO I and as a result substantially all of the assets were sold.
|
|
•
|
RSO EquityCo, LLC, a wholly-owned subsidiary, owns
10.0%
of the equity of Apidos CDO I.
|
|
•
|
RCC Residential Portfolio, Inc. ("RCC Resi Portfolio"), a wholly-owned subsidiary, historically invested in residential mortgage-backed securities ("RMBS"). The remaining securities were sold in September 2017.
|
|
•
|
RCC Residential Portfolio TRS, Inc. ("RCC Resi TRS"), a wholly-owned TRS, was formed to hold strategic residential mortgage positions that could not be held by RCC Resi Portfolio. RCC Resi TRS also owns
100.0%
of the equity, unless otherwise stated, in the following:
|
|
◦
|
Primary Capital Mortgage, LLC ("PCM") (formerly known as Primary Capital Advisors, LLC), originated and serviced residential mortgage loans. In November 2016, PCM's operations were reclassified to discontinued operations. PCM sold its residential mortgage loan pipeline, its mortgage servicing rights and its remaining loans held for sale. See
Note 21
for further discussion.
|
|
◦
|
RCM Global Manager, LLC ("RCM Global Manager") owns
63.8%
of RCM Global LLC ("RCM Global"). RCM Global, accounted for as an equity method investment, held a portfolio of investment securities available-for-sale.
|
|
◦
|
RCC Residential Depositor, LLC ("RCC Resi Depositor") owns
100.0%
of RCC Residential Acquisition, LLC ("RCC Resi Acquisition"). Prior to the Plan, RCC Resi Acquisition purchased residential mortgage loans from PCM and transferred the assets to RCC Residential Opportunities Trust ("RCC Opp Trust"). RCC Opp Trust, a wholly-owned statutory trust, held a portfolio of residential mortgage loans, available-for-sale.
|
|
◦
|
Long Term Care Conversion Funding, LLC ("LTCC Funding") provided a financing facility to fund the acquisition of life settlement contracts.
|
|
◦
|
Life Care Funding, LLC ("LCF") was established for the purpose of acquiring life settlement contracts. In July 2017, the Company purchased the balance of the outstanding membership interests of LCF, therefore becoming a single member LLC. In 2018, substantially all the life settlement contracts were sold.
|
|
◦
|
RCC TRS, LLC ("RCC TRS") holds investments in direct financing leases and investment securities, trading. RCC TRS also owns equity in the following:
|
|
▪
|
RCC TRS owns
100.0%
of the equity of Resource TRS, LLC, which in turn holds a
25.8%
investment in New NP, LLC, which is reported in discontinued operations.
|
|
▪
|
RCC TRS owns
44.6%
of the equity in New NP, LLC, which is reported in discontinued operations.
|
|
▪
|
RCC TRS owns
80.2%
of the equity in Pelium Capital, L.P. ("Pelium Capital"). Pelium Capital, accounted for as an equity method investment, held investment securities, trading.
|
|
◦
|
Resource Capital Asset Management, LLC ("RCAM") was entitled to collect senior, subordinated and incentive fees related to CLO issuers to which it provided management services through CVC Credit Partners, LLC ("CVC Credit Partners"), formerly Apidos Capital Management ("ACM"), a subsidiary of CVC Capital Partners SICAV-FIS, S.A. ("CVC"). C-III sold its
24.0%
interest in CVC Credit Partners in August 2017.
|
|
|
As of
|
||||||
|
|
March 31, 2018
|
|
March 31, 2017
|
||||
|
Cash and cash equivalents
|
$
|
61,500
|
|
|
$
|
157,760
|
|
|
Restricted cash
|
546
|
|
|
4,871
|
|
||
|
Total cash, cash equivalents and restricted cash shown on the Company's consolidated statements of cash flows
|
$
|
62,046
|
|
|
$
|
162,631
|
|
|
|
|
CRE Securitizations
|
|
Other
|
|
Total
|
||||||
|
ASSETS
|
|
|
|
|
|
|
||||||
|
Restricted cash
|
|
$
|
2
|
|
|
$
|
511
|
|
|
$
|
513
|
|
|
Accrued interest receivable
|
|
2,728
|
|
|
—
|
|
|
2,728
|
|
|||
|
CRE loans, pledged as collateral
|
|
571,640
|
|
|
—
|
|
|
571,640
|
|
|||
|
Principal paydowns receivable
|
|
—
|
|
|
20
|
|
|
20
|
|
|||
|
Other assets
|
|
188
|
|
|
—
|
|
|
188
|
|
|||
|
Total assets
(1)
|
|
$
|
574,558
|
|
|
$
|
531
|
|
|
$
|
575,089
|
|
|
|
|
|
|
|
|
|
||||||
|
LIABILITIES
|
|
|
|
|
|
|
||||||
|
Borrowings
|
|
$
|
298,970
|
|
|
$
|
—
|
|
|
$
|
298,970
|
|
|
Accrued interest payable
|
|
412
|
|
|
—
|
|
|
412
|
|
|||
|
Accounts payable and other liabilities
|
|
65
|
|
|
—
|
|
|
65
|
|
|||
|
Total liabilities
|
|
$
|
299,447
|
|
|
$
|
—
|
|
|
$
|
299,447
|
|
|
(1)
|
Assets of each of the Consolidated VIEs may only be used to settle the obligations of each respective VIE.
|
|
|
|
Unsecured Junior Subordinated Debentures
|
|
RCM Global LLC
|
|
Pelium Capital
|
|
C40
|
|
Prospect Hackensack
|
|
Total
|
|
Maximum Exposure to Loss
|
||||||||||||||
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Accrued interest receivable
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
18
|
|
|
$
|
18
|
|
|
$
|
—
|
|
|
CRE loans
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,008
|
|
|
19,008
|
|
|
$
|
19,008
|
|
||||||
|
Investment securities available-for-sale
(1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
20,855
|
|
|
—
|
|
|
20,855
|
|
|
$
|
20,763
|
|
||||||
|
Investments in unconsolidated entities
|
|
1,548
|
|
|
217
|
|
|
4,674
|
|
|
—
|
|
|
—
|
|
|
6,439
|
|
|
$
|
6,439
|
|
||||||
|
Total assets
|
|
1,548
|
|
|
217
|
|
|
4,674
|
|
|
20,855
|
|
|
19,026
|
|
|
46,320
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
LIABILITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Borrowings
|
|
51,548
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
51,548
|
|
|
N/A
|
|
|||||||
|
Total liabilities
|
|
51,548
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
51,548
|
|
|
N/A
|
|
|||||||
|
Net asset (liability)
|
|
$
|
(50,000
|
)
|
|
$
|
217
|
|
|
$
|
4,674
|
|
|
$
|
20,855
|
|
|
$
|
19,026
|
|
|
$
|
(5,228
|
)
|
|
N/A
|
|
|
|
(1)
|
The Company's investment in C40 is carried at fair value and its maximum exposure to loss is the amortized cost of the investment.
|
|
|
|
For the Three Months Ended
|
||||||
|
|
|
March 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Non-cash continuing financing activities include the following:
|
|
|
|
|
|
|
||
|
Distributions on common stock accrued but not paid
|
|
$
|
1,584
|
|
|
$
|
1,568
|
|
|
Distribution on preferred stock accrued but not paid
|
|
$
|
1,724
|
|
|
$
|
4,009
|
|
|
Description
|
|
Quantity
|
|
Principal
|
|
Unamortized (Discount)
Premium, net (1) |
|
Amortized Cost
|
|
Allowance for Loan Losses
|
|
Carrying
Value (2) |
|
Contracted Interest Rates
(3)
|
|
Maturity Dates
(4)(5)
|
||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
CRE loans held for investment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
(6)
|
|
75
|
|
$
|
1,369,753
|
|
|
$
|
(7,233
|
)
|
|
$
|
1,362,520
|
|
|
$
|
(4,529
|
)
|
|
$
|
1,357,991
|
|
|
1M LIBOR plus 3.50% to 1M LIBOR plus 6.25% (Floating) and 8.00% (Fixed)
|
|
April 2018 to April 2021
|
|
Preferred equity investment (see Note 3)
(7)(8)
|
|
1
|
|
19,200
|
|
|
(192
|
)
|
|
19,008
|
|
|
—
|
|
|
19,008
|
|
|
11.50%
|
|
April 2025
|
|||||
|
Total CRE loans held for investment
|
|
|
|
1,388,953
|
|
|
(7,425
|
)
|
|
1,381,528
|
|
|
(4,529
|
)
|
|
1,376,999
|
|
|
|
|
|
|||||
|
Total loans
|
|
|
|
$
|
1,388,953
|
|
|
$
|
(7,425
|
)
|
|
$
|
1,381,528
|
|
|
$
|
(4,529
|
)
|
|
$
|
1,376,999
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
CRE loans held for investment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
(6)
|
|
70
|
|
$
|
1,297,164
|
|
|
$
|
(7,014
|
)
|
|
$
|
1,290,150
|
|
|
$
|
(5,328
|
)
|
|
$
|
1,284,822
|
|
|
1M LIBOR plus 3.60% to 1M LIBOR plus 6.25%
|
|
February 2018 to January 2021
|
|
Total CRE loans held for investment
|
|
|
|
1,297,164
|
|
|
(7,014
|
)
|
|
1,290,150
|
|
|
(5,328
|
)
|
|
1,284,822
|
|
|
|
|
|
|||||
|
Syndicated corporate loans
(9)
|
|
2
|
|
13
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|
N/A
|
|
N/A
|
|||||
|
Total loans held for sale
|
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|
|
|
|
|||||
|
Total loans
|
|
|
|
$
|
1,297,177
|
|
|
$
|
(7,014
|
)
|
|
$
|
1,290,163
|
|
|
$
|
(5,328
|
)
|
|
$
|
1,284,835
|
|
|
|
|
|
|
(1)
|
Amounts include unamortized loan origination fees of
$7.1 million
and
$6.7 million
and deferred amendment fees of
$368,000
and
$268,000
being amortized over the life of the loans at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(2)
|
Substantially all loans are pledged as collateral under various borrowings at
March 31, 2018
and
December 31, 2017
.
|
|
(3)
|
LIBOR refers to the London Interbank Offered Rate.
|
|
(4)
|
Maturity dates exclude contracted extension options, subject to the satisfaction of certain terms, that may be available to the borrowers.
|
|
(5)
|
Maturity dates exclude
one
CRE whole loan, with an amortized cost of
$7.0 million
, in default at
March 31, 2018
and
December 31, 2017
.
|
|
(6)
|
CRE whole loans had
$86.2 million
and
$84.1 million
in unfunded loan commitments at
March 31, 2018
and
December 31, 2017
, respectively. These unfunded loan commitments are advanced as the borrowers formally request additional funding, as permitted under the loan agreement, and any necessary approvals have been obtained.
|
|
(7)
|
The interest rate on the Company's preferred equity investment pays currently at
8.00%
. The remaining interest is deferred until maturity.
|
|
(8)
|
Beginning in April 2023, the Company has the right to unilaterally force the sale of the underlying property.
|
|
(9)
|
All syndicated corporate loans are second lien loans and are accounted for under the fair value option.
|
|
Description
|
|
2018
|
|
2019
|
|
2020 and Thereafter
|
|
Total
|
||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
||||||||
|
Whole loans
(1)
|
|
$
|
—
|
|
|
$
|
142,818
|
|
|
$
|
1,212,702
|
|
|
$
|
1,355,520
|
|
|
Preferred equity investment
|
|
—
|
|
|
—
|
|
|
19,008
|
|
|
19,008
|
|
||||
|
Total CRE loans
(1)
|
|
$
|
—
|
|
|
$
|
142,818
|
|
|
$
|
1,231,710
|
|
|
$
|
1,374,528
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Description
|
|
2018
|
|
2019
|
|
2020 and Thereafter
|
|
Total
|
||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
||||||||
|
Whole loans
(1)
|
|
$
|
—
|
|
|
$
|
148,622
|
|
|
$
|
1,134,528
|
|
|
$
|
1,283,150
|
|
|
(1)
|
Excludes
one
CRE whole loan, with an amortized cost of
$7.0 million
, in default at
March 31, 2018
and
December 31, 2017
.
|
|
|
|
Three Months Ended March 31, 2018
|
|
Year Ended December 31, 2017
|
||||||||||||||||||||||||
|
|
|
Commercial Real Estate Loans
|
|
Direct Financing Leases
|
|
Total
|
|
Commercial Real Estate Loans
|
|
Syndicated Corporate Loans
|
|
Direct Financing Leases
|
|
Total
|
||||||||||||||
|
Allowance for loan and lease losses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Allowance for loan and lease losses at beginning of period
|
|
$
|
5,328
|
|
|
$
|
735
|
|
|
$
|
6,063
|
|
|
$
|
3,829
|
|
|
$
|
—
|
|
|
$
|
465
|
|
|
$
|
4,294
|
|
|
Provision for (recovery of) loan and lease losses, net
|
|
(799
|
)
|
|
—
|
|
|
(799
|
)
|
|
1,499
|
|
|
3
|
|
|
270
|
|
|
1,772
|
|
|||||||
|
Loans charged-off
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
|||||||
|
Allowance for loan and lease losses at end of period
|
|
$
|
4,529
|
|
|
$
|
735
|
|
|
$
|
5,264
|
|
|
$
|
5,328
|
|
|
$
|
—
|
|
|
$
|
735
|
|
|
$
|
6,063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||||||
|
|
|
Commercial Real Estate Loans
|
|
Direct Financing Leases
|
|
Total
|
|
Commercial Real Estate Loans
|
|
Syndicated Corporate Loans
|
|
Direct Financing Leases
|
|
Total
|
||||||||||||||
|
Allowance for loan and lease losses ending balance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Individually evaluated for impairment
|
|
$
|
2,500
|
|
|
$
|
—
|
|
|
$
|
2,500
|
|
|
$
|
2,500
|
|
|
$
|
—
|
|
|
$
|
735
|
|
|
$
|
3,235
|
|
|
Collectively evaluated for impairment
|
|
$
|
2,029
|
|
|
$
|
735
|
|
|
$
|
2,764
|
|
|
$
|
2,828
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,828
|
|
|
Loans acquired with deteriorated credit quality
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Loans and Leases:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Amortized cost ending balance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Individually evaluated for impairment
|
|
$
|
26,008
|
|
|
$
|
—
|
|
|
$
|
26,008
|
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
$
|
886
|
|
|
$
|
7,886
|
|
|
Collectively evaluated for impairment
|
|
$
|
1,355,520
|
|
|
$
|
824
|
|
|
$
|
1,356,344
|
|
|
$
|
1,283,150
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,283,150
|
|
|
Loans acquired with deteriorated credit quality
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
Risk Rating
|
|
Risk Characteristics
|
|
|
|
|
|
1
|
|
• Property performance has surpassed underwritten expectations.
|
|
|
|
• Occupancy is stabilized, the property has had a history of consistently high occupancy, and the property has a diverse and high quality tenant mix.
|
|
|
|
|
|
2
|
|
• Property performance is consistent with underwritten expectations and covenants and performance criteria are being met or exceeded.
|
|
|
|
• Occupancy is stabilized, near stabilized or is on track with underwriting.
|
|
|
|
|
|
3
|
|
• Property performance lags behind underwritten expectations.
|
|
|
|
• Occupancy is not stabilized and the property has some tenancy rollover.
|
|
|
|
|
|
4
|
|
• Property performance significantly lags behind underwritten expectations. Performance criteria and loan covenants have required occasional waivers.
|
|
|
|
• Occupancy is not stabilized and the property has a large amount of tenancy rollover.
|
|
|
|
|
|
5
|
|
• Property performance is significantly worse than underwritten expectations. The loan is not in compliance with loan covenants and performance criteria and is in default. Expected sale proceeds would not be sufficient to pay off the loan at maturity.
|
|
|
|
• The property has material vacancy and significant rollover of remaining tenants.
|
|
|
|
• An updated appraisal is required.
|
|
|
Rating 1
|
|
Rating 2
|
|
Rating 3
|
|
Rating 4
|
|
Rating 5
|
|
Held for Sale
|
|
Total
|
||||||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Whole loans
(1)
|
$
|
52,010
|
|
|
$
|
1,179,981
|
|
|
$
|
118,688
|
|
|
$
|
4,841
|
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
$
|
1,362,520
|
|
|
Preferred equity investment
(2)
|
—
|
|
|
19,008
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,008
|
|
|||||||
|
Legacy CRE whole loans
(3)(4)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
63,882
|
|
|
63,882
|
|
|||||||
|
|
$
|
52,010
|
|
|
$
|
1,198,989
|
|
|
$
|
118,688
|
|
|
$
|
4,841
|
|
|
$
|
7,000
|
|
|
$
|
63,882
|
|
|
$
|
1,445,410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Whole loans
(1)
|
$
|
65,589
|
|
|
$
|
1,040,883
|
|
|
$
|
171,841
|
|
|
$
|
4,837
|
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
$
|
1,290,150
|
|
|
Legacy CRE whole loans
(3)(4)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
63,783
|
|
|
63,783
|
|
|||||||
|
|
$
|
65,589
|
|
|
$
|
1,040,883
|
|
|
$
|
171,841
|
|
|
$
|
4,837
|
|
|
$
|
7,000
|
|
|
$
|
63,783
|
|
|
$
|
1,353,933
|
|
|
(1)
|
Includes
one
CRE whole loan, with an amortized cost of
$7.0 million
, that was in default at
March 31, 2018
and
December 31, 2017
.
|
|
(2)
|
The Company's preferred equity investment is evaluated individually for impairment and excluded from the general reserve calculation.
|
|
(3)
|
Legacy CRE whole loans are carried at the lower of cost or fair value.
|
|
(4)
|
Includes
three
and
two
legacy CRE whole loans that were in default with total carrying values of
$40.5 million
and
$22.5 million
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
•
|
One
CRE whole loan collateralized by an office property in the Mountain region, as defined by the NCREIF, with an initial par value of
$17.7 million
. Upon transfer to held for sale in 2016, this loan was written down to its estimated fair value of
$11.0 million
, which remains the carrying value at
March 31, 2018
and
December 31, 2017
.
No
additional valuation adjustments were recognized for the
three months ended March 31, 2018
and
2017
. The loan matured in May 2017 and is currently in default;
|
|
•
|
One
CRE whole loan collateralized by a hotel in the Pacific region, as defined by the NCREIF, with an initial par value of
$29.5 million
. Upon transfer to held for sale in 2016, this loan was written down to its estimated fair value of
$24.0 million
. At
March 31, 2018
and
December 31, 2017
, the loan had a carrying value of
$18.0 million
and
$22.5 million
, respectively. An additional fair value adjustment of
$4.7 million
, which included protective advances of
$172,000
, to reduce the carrying value was recognized during the
three months ended March 31, 2018
. This adjustment was recorded based on the receipt of updated appraisals in April 2018 and was recognized in fair value adjustments on financial assets held for sale in the Company's consolidated statements of operations.
No
valuation adjustments were recognized for the
three months ended March 31, 2017
. The loan has a maturity date in January 2019 and is currently in default.
|
|
|
30-59 Days
|
|
60-89 Days
|
|
Greater than 90 Days
|
|
Total Past Due
|
|
Current
|
|
Total Loans Receivable
(1)
|
|
Total Loans > 90 Days and Accruing
|
||||||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Whole loans
(2)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
1,355,520
|
|
|
$
|
1,362,520
|
|
|
$
|
—
|
|
|
Preferred equity investment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,008
|
|
|
19,008
|
|
|
—
|
|
|||||||
|
Legacy CRE whole loans
(3)
|
—
|
|
|
—
|
|
|
47,057
|
|
|
47,057
|
|
|
16,825
|
|
|
63,882
|
|
|
11,516
|
|
|||||||
|
Total loans
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
54,057
|
|
|
$
|
54,057
|
|
|
$
|
1,391,353
|
|
|
$
|
1,445,410
|
|
|
$
|
11,516
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Whole loans
(2)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
1,283,150
|
|
|
$
|
1,290,150
|
|
|
$
|
—
|
|
|
Legacy CRE whole loans
(3)
|
11,516
|
|
|
—
|
|
|
11,000
|
|
|
22,516
|
|
|
41,267
|
|
|
63,783
|
|
|
—
|
|
|||||||
|
Total loans
|
$
|
11,516
|
|
|
$
|
—
|
|
|
$
|
18,000
|
|
|
$
|
29,516
|
|
|
$
|
1,324,417
|
|
|
$
|
1,353,933
|
|
|
$
|
—
|
|
|
(1)
|
Excludes direct financing leases of
$89,000
and
$151,000
, net of reserves, at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(2)
|
Includes
one
CRE whole loan, with an amortized cost of
$7.0 million
, that was in default at
March 31, 2018
and
December 31, 2017
.
|
|
(3)
|
Includes
three
and
two
legacy CRE whole loans that were in default with total carrying values of
$40.5 million
and
$22.5 million
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
|
Recorded Balance
|
|
Unpaid Principal Balance
|
|
Specific Allowance
|
|
Average Investment in Impaired Loans
|
|
Interest Income Recognized
|
||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Loans without a specific valuation allowance:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Loans with a specific valuation allowance:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
(2,500
|
)
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
Total:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Whole loans
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
(2,500
|
)
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Loans without a specific valuation allowance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Whole loans
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Loans with a specific valuation allowance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Whole loans
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
(2,500
|
)
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
Total:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Whole loans
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
(2,500
|
)
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
Amortized Cost
|
|
Unrealized Gains
|
|
Unrealized Losses
|
|
Fair Value
|
||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Structured notes
|
|
2
|
|
$
|
1,218
|
|
|
$
|
—
|
|
|
$
|
(1,054
|
)
|
|
$
|
164
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Structured notes
|
|
4
|
|
$
|
2,891
|
|
|
$
|
—
|
|
|
$
|
(2,713
|
)
|
|
$
|
178
|
|
|
|
Amortized Cost
|
|
Unrealized Gains
|
|
Unrealized Losses
|
|
Fair Value
(1)
|
||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
||||||||
|
CMBS
|
$
|
251,343
|
|
|
$
|
1,443
|
|
|
$
|
(2,040
|
)
|
|
$
|
250,746
|
|
|
Total
|
$
|
251,343
|
|
|
$
|
1,443
|
|
|
$
|
(2,040
|
)
|
|
$
|
250,746
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
CMBS
|
$
|
210,806
|
|
|
$
|
1,947
|
|
|
$
|
(1,174
|
)
|
|
$
|
211,579
|
|
|
ABS
|
259
|
|
|
—
|
|
|
(101
|
)
|
|
158
|
|
||||
|
Total
|
$
|
211,065
|
|
|
$
|
1,947
|
|
|
$
|
(1,275
|
)
|
|
$
|
211,737
|
|
|
(1)
|
At
March 31, 2018
and
December 31, 2017
,
$227.7 million
and
$169.6 million
, respectively, of investment securities available-for-sale were pledged as collateral under related financings.
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||
|
|
Amortized
Cost
|
|
Fair Value
|
|
Weighted Average Coupon
|
|
Amortized
Cost
|
|
Fair Value
|
|
Weighted Average Coupon
|
||||||||
|
Less than one year
(1)
|
$
|
22,642
|
|
|
$
|
22,415
|
|
|
5.36%
|
|
$
|
25,475
|
|
|
$
|
25,275
|
|
|
5.55%
|
|
Greater than one year and less than five years
|
145,562
|
|
|
146,081
|
|
|
4.79%
|
|
126,273
|
|
|
127,104
|
|
|
4.65%
|
||||
|
Greater than five years and less than ten years
|
83,139
|
|
|
82,250
|
|
|
3.55%
|
|
59,317
|
|
|
59,358
|
|
|
3.53%
|
||||
|
Total
|
$
|
251,343
|
|
|
$
|
250,746
|
|
|
4.43%
|
|
$
|
211,065
|
|
|
$
|
211,737
|
|
|
4.45%
|
|
(1)
|
The Company expects that the payoff dates of these CMBS and ABS will either be extended or that the securities will be paid off in full.
|
|
|
Less than 12 Months
|
|
More than 12 Months
|
|
Total
|
|||||||||||||||||||||||||||
|
|
Fair
Value |
|
Unrealized Losses
|
|
Number of
Securities |
|
Fair
Value |
|
Unrealized Losses
|
|
Number of
Securities |
|
Fair
Value |
|
Unrealized Losses
|
|
Number of
Securities |
|||||||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
CMBS
|
$
|
92,454
|
|
|
$
|
(1,674
|
)
|
|
20
|
|
|
$
|
1,226
|
|
|
$
|
(366
|
)
|
|
4
|
|
|
$
|
93,680
|
|
|
$
|
(2,040
|
)
|
|
24
|
|
|
Total temporarily impaired securities
|
$
|
92,454
|
|
|
$
|
(1,674
|
)
|
|
20
|
|
|
$
|
1,226
|
|
|
$
|
(366
|
)
|
|
4
|
|
|
$
|
93,680
|
|
|
$
|
(2,040
|
)
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
CMBS
|
$
|
49,016
|
|
|
$
|
(888
|
)
|
|
12
|
|
|
$
|
1,308
|
|
|
$
|
(286
|
)
|
|
4
|
|
|
$
|
50,324
|
|
|
$
|
(1,174
|
)
|
|
16
|
|
|
ABS
|
158
|
|
|
(101
|
)
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
158
|
|
|
(101
|
)
|
|
1
|
|
||||||
|
Total temporarily impaired securities
|
$
|
49,174
|
|
|
$
|
(989
|
)
|
|
13
|
|
|
$
|
1,308
|
|
|
$
|
(286
|
)
|
|
4
|
|
|
$
|
50,482
|
|
|
$
|
(1,275
|
)
|
|
17
|
|
|
|
For the Three Months Ended
|
||||||||||||||||||||
|
|
Positions Sold
|
|
Positions Redeemed
|
|
Par Amount Sold/Redeemed
|
|
Amortized Cost
|
|
Realized Gain (Loss)
|
|
Proceeds
|
||||||||||
|
March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
ABS
|
2
|
|
|
—
|
|
|
$
|
411
|
|
|
$
|
265
|
|
|
$
|
(217
|
)
|
|
$
|
48
|
|
|
Total
|
2
|
|
|
—
|
|
|
$
|
411
|
|
|
$
|
265
|
|
|
$
|
(217
|
)
|
|
$
|
48
|
|
|
|
|
|
|
|
|
|
Equity in (Losses) Earnings of Unconsolidated Entities
|
||||||||||
|
|
Ownership % at March 31, 2018
|
|
March 31,
2018 |
|
December 31,
2017 |
|
For the Three Months Ended March 31, 2018
|
|
For the Three Months Ended March 31, 2017
|
||||||||
|
|
|
|
|
|
|||||||||||||
|
Pelium Capital Partners, L.P.
(1)
|
80.2%
|
|
$
|
4,674
|
|
|
$
|
10,503
|
|
|
$
|
(305
|
)
|
|
$
|
(158
|
)
|
|
RCM Global, LLC
|
63.8%
|
|
217
|
|
|
—
|
|
|
13
|
|
|
(4
|
)
|
||||
|
Pearlmark Mezzanine Realty Partners IV, L.P.
(2)
|
—%
|
|
—
|
|
|
—
|
|
|
—
|
|
|
358
|
|
||||
|
Investment in LCC Preferred Stock
(3)
|
—%
|
|
—
|
|
|
—
|
|
|
—
|
|
|
165
|
|
||||
|
Subtotal
|
|
|
4,891
|
|
|
10,503
|
|
|
(292
|
)
|
|
361
|
|
||||
|
Investment in RCT I and II
(4)
|
3.0%
|
|
1,548
|
|
|
1,548
|
|
|
(724
|
)
|
|
(637
|
)
|
||||
|
Total
|
|
|
$
|
6,439
|
|
|
$
|
12,051
|
|
|
$
|
(1,016
|
)
|
|
$
|
(276
|
)
|
|
(1)
|
During the
three months ended
March 31, 2018
and
2017
, the Company received distributions of
$5.6 million
and
$13.6 million
, respectively, on its investment in Pelium Capital.
|
|
(2)
|
The Company sold its investment in Pearlmark Mezz in May 2017.
|
|
(3)
|
The Company's investment in LCC liquidated in July 2017 as a result of the sale of LCC.
|
|
(4)
|
During the
three months ended
March 31, 2018
and
2017
, distributions from the trusts are recorded in interest expense on the Company's consolidated statements of operations as the investments are accounted for under the cost method.
|
|
|
Principal Outstanding
|
|
Unamortized Issuance Costs and Discounts
|
|
Outstanding Borrowings
|
|
Weighted Average Borrowing Rate
|
|
Weighted Average Remaining Maturity
|
|
Value of Collateral
|
||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
RCC 2015-CRE3 Senior Notes
|
$
|
16,592
|
|
|
$
|
165
|
|
|
$
|
16,427
|
|
|
5.79%
|
|
14.0 years
|
|
$
|
80,632
|
|
|
RCC 2015-CRE4 Senior Notes
|
47,663
|
|
|
368
|
|
|
47,295
|
|
|
4.66%
|
|
14.4 years
|
|
136,846
|
|
||||
|
RCC 2017-CRE5 Senior Notes
|
238,454
|
|
|
3,205
|
|
|
235,249
|
|
|
2.82%
|
|
16.3 years
|
|
357,234
|
|
||||
|
Unsecured Junior Subordinated Debentures
|
51,548
|
|
|
—
|
|
|
51,548
|
|
|
5.99%
|
|
18.4 years
|
|
—
|
|
||||
|
4.50% Convertible Senior Notes
|
143,750
|
|
|
15,878
|
|
|
127,872
|
|
|
4.50%
|
|
4.4 years
|
|
—
|
|
||||
|
6.00% Convertible Senior Notes
|
70,453
|
|
|
677
|
|
|
69,776
|
|
|
6.00%
|
|
245 days
|
|
—
|
|
||||
|
8.00% Convertible Senior Notes
|
21,182
|
|
|
409
|
|
|
20,773
|
|
|
8.00%
|
|
1.8 years
|
|
—
|
|
||||
|
CRE - Term Repurchase Facilities
(1)
|
430,987
|
|
|
602
|
|
|
430,385
|
|
|
4.09%
|
|
132 days
|
|
622,204
|
|
||||
|
CMBS - Term Repurchase Facility
(2)
|
13,532
|
|
|
—
|
|
|
13,532
|
|
|
3.99%
|
|
55 days
|
|
20,372
|
|
||||
|
Trust Certificates - Term Repurchase Facilities
(3)
|
74,125
|
|
|
494
|
|
|
73,631
|
|
|
6.29%
|
|
1.8 years
|
|
207,901
|
|
||||
|
CMBS - Short Term Repurchase Agreements
(4)
|
135,898
|
|
|
—
|
|
|
135,898
|
|
|
3.13%
|
|
25 days
|
|
207,283
|
|
||||
|
Total
|
$
|
1,244,184
|
|
|
$
|
21,798
|
|
|
$
|
1,222,386
|
|
|
4.22%
|
|
5.4 years
|
|
$
|
1,632,472
|
|
|
|
Principal Outstanding
|
|
Unamortized Issuance Costs and Discounts
|
|
Outstanding Borrowings
|
|
Weighted Average Borrowing Rate
|
|
Weighted Average Remaining Maturity
|
|
Value of Collateral
|
||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
RCC 2015-CRE3 Senior Notes
|
$
|
85,788
|
|
|
$
|
396
|
|
|
$
|
85,392
|
|
|
4.50%
|
|
14.2 years
|
|
$
|
149,828
|
|
|
RCC 2015-CRE4 Senior Notes
|
90,883
|
|
|
407
|
|
|
90,476
|
|
|
3.65%
|
|
14.6 years
|
|
180,066
|
|
||||
|
RCC 2017-CRE5 Senior Notes
|
244,280
|
|
|
3,493
|
|
|
240,787
|
|
|
2.51%
|
|
16.6 years
|
|
369,534
|
|
||||
|
Unsecured Junior Subordinated Debentures
|
51,548
|
|
|
—
|
|
|
51,548
|
|
|
5.49%
|
|
18.7 years
|
|
—
|
|
||||
|
4.50% Convertible Senior Notes
|
143,750
|
|
|
16,626
|
|
|
127,124
|
|
|
4.50%
|
|
4.6 years
|
|
—
|
|
||||
|
6.00% Convertible Senior Notes
|
70,453
|
|
|
928
|
|
|
69,525
|
|
|
6.00%
|
|
335 days
|
|
—
|
|
||||
|
8.00% Convertible Senior Notes
|
21,182
|
|
|
466
|
|
|
20,716
|
|
|
8.00%
|
|
2.0 years
|
|
—
|
|
||||
|
CRE - Term Repurchase Facilities
(1)
|
292,511
|
|
|
1,013
|
|
|
291,498
|
|
|
3.82%
|
|
222 days
|
|
432,125
|
|
||||
|
CMBS - Term Repurchase Facilities
(2)
|
27,628
|
|
|
—
|
|
|
27,628
|
|
|
3.05%
|
|
121 days
|
|
38,060
|
|
||||
|
Trust Certificates - Term Repurchase Facilities
(3)
|
76,714
|
|
|
570
|
|
|
76,144
|
|
|
5.97%
|
|
2.1 years
|
|
214,375
|
|
||||
|
CMBS - Short Term Repurchase Agreements
(4)
|
82,647
|
|
|
—
|
|
|
82,647
|
|
|
2.79%
|
|
14 days
|
|
131,522
|
|
||||
|
Total
|
$
|
1,187,384
|
|
|
$
|
23,899
|
|
|
$
|
1,163,485
|
|
|
4.00%
|
|
7.3 years
|
|
$
|
1,515,510
|
|
|
(1)
|
Principal outstanding includes
accrued interest payable
of
$689,000
and
$534,000
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(2)
|
Principal outstanding includes
accrued interest payable
of
$35,000
and
$46,000
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(3)
|
Principal outstanding includes
accrued interest payable
of
$194,000
and
$203,000
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(4)
|
Principal outstanding includes
accrued interest payable
of
$470,000
and
$279,000
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
Securitization
|
|
Closing Date
|
|
Maturity Date
|
|
End of Designated Principal Reinvestment Period
(1)
|
|
Total Note Paydowns Received from Closing Date through March 31, 2018
|
||
|
RCC 2015-CRE3
|
|
February 2015
|
|
March 2032
|
|
February 2017
|
|
$
|
265,535
|
|
|
RCC 2015-CRE4
|
|
August 2015
|
|
August 2032
|
|
September 2017
|
|
$
|
176,072
|
|
|
RCC 2017-CRE5
|
|
July 2017
|
|
July 2034
|
|
July 2020
|
|
$
|
12,995
|
|
|
(1)
|
The designated principal reinvestment period is the period where principal payments received by each respective securitization may be designated by the Company to purchase funding participations of existing collateral originally underwritten at the close of each securitization, which was funded outside of the deal structure.
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
|
|
Outstanding Borrowings
(1)
|
|
Value of Collateral
|
|
Number of Positions as Collateral
|
|
Weighted Average Interest Rate
|
|
Outstanding Borrowings
(1)
|
|
Value of Collateral
|
|
Number of Positions as Collateral
|
|
Weighted Average Interest Rate
|
||||||||
|
CRE - Term Repurchase Facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Wells Fargo Bank, N.A.
(2)
|
$
|
258,160
|
|
|
$
|
376,843
|
|
|
23
|
|
3.92%
|
|
$
|
179,347
|
|
|
$
|
268,003
|
|
|
19
|
|
3.68%
|
|
Morgan Stanley Bank, N.A.
(3)
|
172,225
|
|
|
245,361
|
|
|
12
|
|
4.36%
|
|
112,151
|
|
|
164,122
|
|
|
9
|
|
4.05%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
CMBS - Term Repurchase Facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Wells Fargo Bank, N.A.
|
—
|
|
|
—
|
|
|
—
|
|
—%
|
|
12,272
|
|
|
14,984
|
|
|
8
|
|
2.45%
|
||||
|
Deutsche Bank AG
|
13,532
|
|
|
20,372
|
|
|
14
|
|
3.99%
|
|
15,356
|
|
|
23,076
|
|
|
14
|
|
3.53%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Trust Certificates - Term Repurchase Facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
RSO Repo SPE Trust 2015
(4)
|
26,583
|
|
|
89,121
|
|
|
2
|
|
7.29%
|
|
26,548
|
|
|
89,121
|
|
|
2
|
|
6.98%
|
||||
|
RSO Repo SPE Trust 2017
(5)
|
47,048
|
|
|
118,780
|
|
|
2
|
|
5.74%
|
|
49,596
|
|
|
125,254
|
|
|
2
|
|
5.43%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
CMBS - Short-Term Repurchase Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
RBC Capital Markets, LLC
|
125,369
|
|
|
173,574
|
|
|
15
|
|
3.11%
|
|
72,131
|
|
|
97,745
|
|
|
6
|
|
2.77%
|
||||
|
JP Morgan Securities LLC
|
10,529
|
|
|
33,709
|
|
|
2
|
|
3.41%
|
|
10,516
|
|
|
33,777
|
|
|
2
|
|
2.93%
|
||||
|
Total
|
$
|
653,446
|
|
|
$
|
1,057,760
|
|
|
|
|
|
|
$
|
477,917
|
|
|
$
|
816,082
|
|
|
|
|
|
|
(1)
|
Outstanding borrowings includes
accrued interest payable
.
|
|
(2)
|
Includes
$313,000
and
$565,000
of deferred debt issuance costs at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(3)
|
Includes
$289,000
and
$448,000
of deferred debt issuance costs at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(4)
|
Includes
$96,000
and
$133,000
of deferred debt issuance costs at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(5)
|
Includes
$292,000
and
$320,000
of deferred debt issuance costs at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
|
Amount at Risk
(1)
|
|
Weighted Average Remaining
Maturity |
|
Weighted Average
Interest Rate |
||
|
At March 31, 2018:
|
|
|
|
|
|
||
|
CRE - Term Repurchase Facilities
|
|
|
|
|
|
||
|
Wells Fargo Bank, N.A.
|
$
|
119,979
|
|
|
112 days
|
|
3.92%
|
|
Morgan Stanley Bank, N.A.
|
$
|
73,843
|
|
|
163 days
|
|
4.36%
|
|
|
|
|
|
|
|
||
|
CMBS - Term Repurchase Facility
|
|
|
|
|
|
||
|
Deutsche Bank AG
|
$
|
6,899
|
|
|
55 days
|
|
3.99%
|
|
|
|
|
|
|
|
||
|
Trust Certificates Term Repurchase Facilities
|
|
|
|
|
|
||
|
RSO Repo SPE Trust 2015
|
$
|
62,515
|
|
|
234 days
|
|
7.29%
|
|
RSO Repo SPE Trust 2017
|
$
|
71,438
|
|
|
2.5 years
|
|
5.74%
|
|
|
|
|
|
|
|
||
|
CMBS - Short-Term Repurchase Agreements
|
|
|
|
|
|
||
|
RBC Capital Markets, LLC
|
$
|
48,635
|
|
|
22 days
|
|
3.11%
|
|
JP Morgan Securities LLC
|
$
|
23,264
|
|
|
60 days
|
|
3.41%
|
|
(1)
|
Equal to the total of the estimated fair value of securities or loans sold and
accrued interest receivable
, minus the total of the repurchase agreement liabilities and
accrued interest payable
.
|
|
|
Total
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
2022 and Thereafter
|
||||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
CRE securitizations
|
$
|
298,971
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
298,971
|
|
|
Unsecured junior subordinated debentures
|
51,548
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
51,548
|
|
||||||
|
4.50% Convertible Senior Notes
|
127,872
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
127,872
|
|
||||||
|
6.00% Convertible Senior Notes
|
69,776
|
|
|
69,776
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
8.00% Convertible Senior Notes
|
20,773
|
|
|
—
|
|
|
—
|
|
|
20,773
|
|
|
—
|
|
|
—
|
|
||||||
|
Repurchase and credit facilities
|
653,446
|
|
|
606,398
|
|
|
—
|
|
|
47,048
|
|
|
—
|
|
|
—
|
|
||||||
|
Total
|
$
|
1,222,386
|
|
|
$
|
676,174
|
|
|
$
|
—
|
|
|
$
|
67,821
|
|
|
$
|
—
|
|
|
$
|
478,391
|
|
|
|
|
Non-Employee Directors
|
|
Non-Employees
(1)
|
|
Former Employees
|
|
Total
|
||||
|
Unvested shares at January 1, 2018
|
|
34,565
|
|
|
419,862
|
|
|
28,646
|
|
|
483,073
|
|
|
Issued
|
|
20,029
|
|
|
209,355
|
|
|
—
|
|
|
229,384
|
|
|
Vested
|
|
(22,692
|
)
|
|
(195,112
|
)
|
|
(27,120
|
)
|
|
(244,924
|
)
|
|
Forfeited
|
|
—
|
|
|
(1,725
|
)
|
|
—
|
|
|
(1,725
|
)
|
|
Unvested shares at March 31, 2018
|
|
31,902
|
|
|
432,380
|
|
|
1,526
|
|
|
465,808
|
|
|
(1)
|
Non-employees are employees of C-III or Resource America.
|
|
Date
|
|
Shares
|
|
Vesting per Year
|
|
Vesting Date(s)
|
|
January 18, 2018
|
|
209,355
|
|
33.3%
|
|
January 18, 2019, January 18, 2020 and January 18, 2021
|
|
February 1, 2018
|
|
3,727
|
|
100.0%
|
|
February 1, 2019
|
|
March 8, 2018
|
|
16,302
|
|
100.0%
|
|
March 8, 2019
|
|
Vested Options
|
|
Number of Options
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Term (in years)
|
|
Aggregate Intrinsic Value (in thousands)
|
|||||
|
Vested at January 1, 2018
|
|
10,000
|
|
|
$
|
25.60
|
|
|
|
|
|
||
|
Vested
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Exercised
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Forfeited
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Expired
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Vested at March 31, 2018
|
|
10,000
|
|
|
$
|
25.60
|
|
|
3.13
|
|
$
|
—
|
|
|
|
|
For the Three Months Ended
|
||||||
|
|
|
March 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Restricted shares granted to non-employees
(1)
|
|
$
|
895
|
|
|
$
|
715
|
|
|
Restricted shares granted to non-employee directors
|
|
72
|
|
|
73
|
|
||
|
Total equity compensation expense
(2)
|
|
$
|
967
|
|
|
$
|
788
|
|
|
(1)
|
Non-employees are employees of C-III or Resource America.
|
|
(2)
|
Amounts exclude equity compensation expense for employees of PCM, which is included in net income (loss) from discontinued operations, net of tax on the consolidated statement of operations during the
three months ended
March 31, 2017
.
|
|
|
For the Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Net (loss) income from continuing operations
|
$
|
(137
|
)
|
|
$
|
9,174
|
|
|
Net income allocated to preferred shares
|
(5,210
|
)
|
|
(6,014
|
)
|
||
|
Consideration paid in excess of carrying value of preferred shares
|
(7,482
|
)
|
|
—
|
|
||
|
Net loss allocable to non-controlling interest, net of taxes
|
—
|
|
|
101
|
|
||
|
Net (loss) income from continuing operations allocable to common shares
|
(12,829
|
)
|
|
3,261
|
|
||
|
Net income (loss) from discontinued operations, net of tax
|
247
|
|
|
(561
|
)
|
||
|
Net (loss) income allocable to common shares
|
$
|
(12,582
|
)
|
|
$
|
2,700
|
|
|
|
|
|
|
||||
|
Net (loss) income per common share - basic:
|
|
|
|
||||
|
Weighted average number of shares outstanding
|
31,111,315
|
|
|
30,752,006
|
|
||
|
Continuing operations
|
$
|
(0.41
|
)
|
|
$
|
0.11
|
|
|
Discontinued operations
|
0.01
|
|
|
(0.02
|
)
|
||
|
Net (loss) income per common share - basic
|
$
|
(0.40
|
)
|
|
$
|
0.09
|
|
|
|
|
|
|
||||
|
Net (loss) income per common share - diluted:
|
|
|
|
|
|
||
|
Weighted average number of shares outstanding
|
31,111,315
|
|
|
30,752,006
|
|
||
|
Additional shares due to assumed conversion of dilutive instruments
|
—
|
|
|
162,142
|
|
||
|
Adjusted weighted-average number of common shares outstanding
|
31,111,315
|
|
|
30,914,148
|
|
||
|
Continuing operations
|
$
|
(0.41
|
)
|
|
$
|
0.11
|
|
|
Discontinued operations
|
0.01
|
|
|
(0.02
|
)
|
||
|
Net (loss) income per common share - diluted
|
$
|
(0.40
|
)
|
|
$
|
0.09
|
|
|
|
|
|
|
||||
|
Potentially dilutive shares excluded from calculation due to anti-dilutive effect
(1)
|
14,885,289
|
|
|
9,002,864
|
|
||
|
(1)
|
Potentially dilutive shares issuable in connection with the potential conversion of the Company's
4.50%
convertible senior notes due 2022 ("
4.50%
Convertible Senior Notes"),
6.00%
convertible senior notes due 2018 ("
6.00%
Convertible Senior Notes") and
8.00%
convertible senior notes due 2020 ("
8.00%
Convertible Senior Notes") (
see Note 10
) were not included in the calculation of diluted net income (loss) per share because the effect would be anti-dilutive.
|
|
|
Net Unrealized Gain on Derivatives
|
|
Net Unrealized Gain (Loss) on Investment Securities Available-for-Sale
|
|
Accumulated Other Comprehensive Income (Loss)
|
||||||
|
Balance at January 1, 2018
|
$
|
602
|
|
|
$
|
695
|
|
|
$
|
1,297
|
|
|
Other comprehensive income (loss) before reclassifications (net of taxes of $27)
|
1,149
|
|
|
(1,509
|
)
|
|
(360
|
)
|
|||
|
Amounts reclassified from accumulated other comprehensive income
(1)
|
—
|
|
|
217
|
|
|
217
|
|
|||
|
Balance at March 31, 2018
|
$
|
1,751
|
|
|
$
|
(597
|
)
|
|
$
|
1,154
|
|
|
(1)
|
Amounts reclassified from
accumulated other comprehensive income
are reclassified to
net realized and unrealized (loss) gain on investment securities available-for-sale and loans and derivatives
on the Company's consolidated statements of operations.
|
|
|
|
Common Stock
|
||||||||
|
|
|
Date Paid
|
|
Total
Dividend Paid |
|
Dividend
Per Share |
||||
|
|
|
|
|
(in thousands)
|
|
|
||||
|
2018
|
|
|
|
|
|
|
||||
|
March 31
|
|
April 27
|
|
$
|
1,584
|
|
|
$
|
0.05
|
|
|
|
|
|
|
|
|
|
||||
|
2017
|
|
|
|
|
|
|
||||
|
March 31
|
|
April 27
|
|
$
|
1,568
|
|
|
$
|
0.05
|
|
|
June 30
|
|
July 28
|
|
$
|
1,567
|
|
|
$
|
0.05
|
|
|
September 30
|
|
October 27
|
|
$
|
1,566
|
|
|
$
|
0.05
|
|
|
December 31
|
|
January 26, 2018
|
|
$
|
1,572
|
|
|
$
|
0.05
|
|
|
|
Series A Preferred Stock
|
|
Series B Preferred Stock
|
|
Series C Preferred Stock
|
||||||||||||||||||||||||
|
|
Date Paid
|
|
Total
Dividend Paid |
|
Dividend
Per Share |
|
Date Paid
|
|
Total
Dividend Paid |
|
Dividend
Per Share |
|
Date Paid
|
|
Total
Dividend Paid |
|
Dividend
Per Share |
||||||||||||
|
|
|
|
(in thousands)
|
|
|
|
|
|
(in thousands)
|
|
|
|
|
|
(in thousands)
|
|
|
||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
March 26
|
N/A
|
|
N/A
|
|
N/A
|
|
March 26
|
|
$
|
1,480
|
|
|
$
|
0.320830
|
|
|
N/A
|
|
N/A
|
|
N/A
|
||||||||
|
March 31
|
N/A
|
|
N/A
|
|
N/A
|
|
N/A
|
|
N/A
|
|
N/A
|
|
April 30
|
|
$
|
2,588
|
|
|
$
|
0.539063
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
March 31
|
May 1
|
|
$
|
568
|
|
|
$
|
0.531250
|
|
|
May 1
|
|
$
|
2,859
|
|
|
$
|
0.515625
|
|
|
May 1
|
|
$
|
2,588
|
|
|
$
|
0.539063
|
|
|
June 30
|
July 31
|
|
$
|
568
|
|
|
$
|
0.531250
|
|
|
July 31
|
|
$
|
2,859
|
|
|
$
|
0.515625
|
|
|
July 31
|
|
$
|
2,588
|
|
|
$
|
0.539063
|
|
|
September 30
|
October 30
|
|
$
|
568
|
|
|
$
|
0.531250
|
|
|
October 30
|
|
$
|
2,859
|
|
|
$
|
0.515625
|
|
|
October 30
|
|
$
|
2,588
|
|
|
$
|
0.539063
|
|
|
December 31
|
January 30, 2018
|
|
$
|
568
|
|
|
$
|
0.531250
|
|
|
January 30, 2018
|
|
$
|
2,859
|
|
|
$
|
0.515625
|
|
|
January 30, 2018
|
|
$
|
2,588
|
|
|
$
|
0.539063
|
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Investment securities available-for-sale
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
250,746
|
|
|
$
|
250,746
|
|
|
Investment securities, trading
|
—
|
|
|
—
|
|
|
164
|
|
|
164
|
|
||||
|
Derivatives
|
—
|
|
|
1,751
|
|
|
—
|
|
|
1,751
|
|
||||
|
Total assets at fair value
|
$
|
—
|
|
|
$
|
1,751
|
|
|
$
|
250,910
|
|
|
$
|
252,661
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Investment securities available-for-sale
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
211,737
|
|
|
$
|
211,737
|
|
|
Investment securities, trading
|
—
|
|
|
—
|
|
|
178
|
|
|
178
|
|
||||
|
Loans held for sale
|
—
|
|
|
—
|
|
|
13
|
|
|
13
|
|
||||
|
Derivatives
|
—
|
|
|
602
|
|
|
—
|
|
|
602
|
|
||||
|
Total assets at fair value
|
$
|
—
|
|
|
$
|
602
|
|
|
$
|
211,928
|
|
|
$
|
212,530
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Derivatives
|
$
|
—
|
|
|
$
|
76
|
|
|
$
|
—
|
|
|
$
|
76
|
|
|
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
76
|
|
|
$
|
—
|
|
|
$
|
76
|
|
|
|
CMBS
|
|
ABS
|
|
Structured Notes
|
|
Loans Held for Sale
|
|
Total
|
||||||||||
|
Balance, January 1, 2018
|
$
|
211,579
|
|
|
$
|
158
|
|
|
$
|
178
|
|
|
$
|
13
|
|
|
$
|
211,928
|
|
|
Included in earnings
(1)
|
639
|
|
|
(217
|
)
|
|
(3
|
)
|
|
7
|
|
|
426
|
|
|||||
|
Purchases
|
43,275
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
43,275
|
|
|||||
|
Sales
|
—
|
|
|
(48
|
)
|
|
(11
|
)
|
|
—
|
|
|
(59
|
)
|
|||||
|
Paydowns
|
(3,379
|
)
|
|
—
|
|
|
—
|
|
|
(20
|
)
|
|
(3,399
|
)
|
|||||
|
Capitalized interest
|
—
|
|
|
7
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|||||
|
Included in OCI
|
(1,368
|
)
|
|
100
|
|
|
—
|
|
|
—
|
|
|
(1,268
|
)
|
|||||
|
Balance, March 31, 2018
|
$
|
250,746
|
|
|
$
|
—
|
|
|
$
|
164
|
|
|
$
|
—
|
|
|
$
|
250,910
|
|
|
(1)
|
For loans held for sale classified as Level 3 at
March 31, 2018
, the Company recorded changes in unrealized gains of
$7,000
for the
three months ended March 31, 2018
, in fair value adjustments on assets held for sale on the consolidated statements of operations.
|
|
|
|
|
Fair Value Measurements
|
||||||||||||||||
|
|
Carrying Amount
|
|
Fair Value
|
|
Quoted Prices in Active Markets for Identical Assets of Liabilities (Level 1)
|
|
Significant Other Observable Inputs (Level 2)
|
|
Significant Unobservable Inputs (Level 3)
|
||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Loans held for investment
|
$
|
1,357,991
|
|
|
$
|
1,367,253
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,367,253
|
|
|
CRE preferred equity investment
|
$
|
19,008
|
|
|
$
|
19,200
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
19,200
|
|
|
Legacy CRE whole loans held for sale
|
$
|
57,341
|
|
|
$
|
58,341
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
58,341
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Senior notes in CRE securitizations
|
$
|
298,971
|
|
|
$
|
302,188
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
302,188
|
|
|
Junior subordinated notes
|
$
|
51,548
|
|
|
$
|
28,584
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
28,584
|
|
|
Convertible notes
|
$
|
218,421
|
|
|
$
|
235,385
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
235,385
|
|
|
Repurchase agreements
|
$
|
653,446
|
|
|
$
|
654,436
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
654,436
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Loans held for investment
|
$
|
1,284,822
|
|
|
$
|
1,294,664
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,294,664
|
|
|
Legacy CRE whole loans held for sale
|
$
|
61,841
|
|
|
$
|
62,841
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
62,841
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Senior notes in CRE securitizations
|
$
|
416,655
|
|
|
$
|
420,084
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
420,084
|
|
|
Junior subordinated notes
|
$
|
51,548
|
|
|
$
|
26,574
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
26,574
|
|
|
Convertible notes
|
$
|
217,365
|
|
|
$
|
235,385
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
235,385
|
|
|
Repurchase agreements
|
$
|
477,917
|
|
|
$
|
479,383
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
479,383
|
|
|
|
Asset Derivatives
|
||||||||
|
|
Notional Amount
|
|
Consolidated Balance Sheets Location
|
|
Fair Value
|
||||
|
Interest rate swap contracts, hedging
(1)
|
$
|
44,570
|
|
|
Derivatives, at fair value
|
|
$
|
1,751
|
|
|
|
|
|
|
|
|
||||
|
|
Liability Derivatives
|
||||||||
|
|
Notional Amount
|
|
Consolidated Balance Sheets Location
|
|
Fair Value
|
||||
|
Interest rate swap contracts, hedging
|
$
|
44,570
|
|
|
Accumulated other comprehensive income
|
|
$
|
1,751
|
|
|
(1)
|
Interest rate swap contracts are accounted for as cash flow hedges.
|
|
|
Asset Derivatives
|
||||||||
|
|
Notional Amount
|
|
Consolidated Balance Sheets Location
|
|
Fair Value
|
||||
|
Interest rate swap contracts, hedging
(1)
|
$
|
41,750
|
|
|
Derivatives, at fair value
|
|
$
|
602
|
|
|
|
|
|
|
|
|
||||
|
|
Liability Derivatives
|
||||||||
|
|
Notional Amount
|
|
Consolidated Balance Sheets Location
|
|
Fair Value
|
||||
|
Forward contracts - foreign currency, hedging
(2)(3)
|
$
|
3,602
|
|
|
Derivatives, at fair value
|
|
$
|
76
|
|
|
Interest rate swap contracts, hedging
|
$
|
41,750
|
|
|
Accumulated other comprehensive income
|
|
$
|
602
|
|
|
(1)
|
Interest rate swap contracts are accounted for as cash flow hedges.
|
|
(2)
|
Foreign currency forward contracts are accounted for as fair value hedges.
|
|
(3)
|
Notional amount is presented on a currency converted basis. The base currency notional amount of the Company's foreign currency hedging forward contracts in a liability position was
€3.0 million
at
December 31, 2017
.
|
|
|
|
Derivatives
|
||||
|
|
|
Consolidated Statements of Operations Location
|
|
Realized and Unrealized Gain (Loss)
(1)
|
||
|
Interest rate swap contracts, hedging
|
|
Interest expense
|
|
$
|
(50
|
)
|
|
(1)
|
Negative values indicate a decrease to the associated consolidated statements of operations line items.
|
|
|
|
Derivatives
|
||||
|
|
|
Consolidated Statements of Operations Location
|
|
Realized and Unrealized Gain (Loss)
(1)
|
||
|
Interest rate swap contracts, hedging
|
|
Interest expense
|
|
$
|
(18
|
)
|
|
Forward contracts - foreign currency, hedging
|
|
Net realized and unrealized (loss) gain on investment securities available-for-sale and loans and derivatives
|
|
$
|
(195
|
)
|
|
(1)
|
Negative values indicate a decrease to the associated consolidated statements of operations line items.
|
|
|
|
|
|
|
|
|
|
(iv)
Gross Amounts Not Offset on the Consolidated Balance Sheets |
|
|
||||||||||||||
|
|
|
(i)
Gross Amounts of Recognized Assets |
|
(ii)
Gross Amounts Offset on the Consolidated Balance Sheets |
|
(iii) = (i) - (ii)
Net Amounts of Assets Included on the Consolidated Balance Sheets |
|
Financial
Instruments |
|
Cash
Collateral Pledged |
|
(v) = (iii) - (iv)
Net Amount |
||||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivatives, at fair value
(1)
|
|
$
|
1,751
|
|
|
$
|
—
|
|
|
$
|
1,751
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,751
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivatives, at fair value
(1)
|
|
$
|
602
|
|
|
$
|
—
|
|
|
$
|
602
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
602
|
|
|
(1)
|
The Company posted cash margin of
$13,000
and
$1.9 million
related to interest rate swap contracts entered into at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
|
|
|
|
|
|
|
|
(iv)
Gross Amounts Not Offset on the Consolidated Balance Sheets |
|
|
||||||||||||||
|
|
|
(i)
Gross Amounts of Recognized Liabilities |
|
(ii)
Gross Amounts Offset on the Consolidated Balance Sheets |
|
(iii) = (i) - (ii)
Net Amounts of Liabilities Included on the Consolidated Balance Sheets |
|
Financial
Instruments (1) |
|
Cash
Collateral Pledged |
|
(v) = (iii) - (iv)
Net Amount |
||||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Repurchase agreements and term facilities
(2)
|
|
$
|
653,446
|
|
|
$
|
—
|
|
|
$
|
653,446
|
|
|
$
|
653,446
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Total
|
|
$
|
653,446
|
|
|
$
|
—
|
|
|
$
|
653,446
|
|
|
$
|
653,446
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivatives, at fair value
|
|
$
|
76
|
|
|
$
|
—
|
|
|
$
|
76
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
76
|
|
|
Repurchase agreements and term facilities
(2)
|
|
477,917
|
|
|
—
|
|
|
477,917
|
|
|
477,917
|
|
|
—
|
|
|
—
|
|
||||||
|
Total
|
|
$
|
477,993
|
|
|
$
|
—
|
|
|
$
|
477,993
|
|
|
$
|
477,917
|
|
|
$
|
—
|
|
|
$
|
76
|
|
|
(1)
|
Amounts represent financial instruments pledged that are available to be offset against liability balances associated with term facilities, repurchase agreements and derivative transactions.
|
|
(2)
|
The combined fair value of securities and loans pledged against the Company's various repurchase agreements and term facilities was
$1.1 billion
and
$816.1 million
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
|
For the Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
REVENUES
|
|
|
|
||||
|
Interest income:
|
|
|
|
||||
|
Loans
|
$
|
570
|
|
|
$
|
897
|
|
|
Other
|
4
|
|
|
13
|
|
||
|
Total interest income
|
574
|
|
|
910
|
|
||
|
Interest expense
|
—
|
|
|
—
|
|
||
|
Net interest income
|
574
|
|
|
910
|
|
||
|
Gain (loss) on sale of residential mortgage loans
|
(14
|
)
|
|
3,825
|
|
||
|
Fee income (loss)
|
99
|
|
|
2,180
|
|
||
|
Total revenues
|
659
|
|
|
6,915
|
|
||
|
OPERATING EXPENSES
|
|
|
|
||||
|
Equity compensation
|
—
|
|
|
59
|
|
||
|
General and administrative
|
660
|
|
|
7,473
|
|
||
|
Total operating expenses
|
660
|
|
|
7,532
|
|
||
|
|
|
|
|
||||
|
|
(1
|
)
|
|
(617
|
)
|
||
|
OTHER INCOME (EXPENSE)
|
|
|
|
||||
|
Net realized and unrealized gain (loss) on investment securities available-for-sale and loans and derivatives
|
248
|
|
|
(2
|
)
|
||
|
Fair value adjustments on financial assets held for sale
|
—
|
|
|
58
|
|
||
|
Total other income (expense)
|
248
|
|
|
56
|
|
||
|
|
|
|
|
||||
|
INCOME (LOSS) FROM DISCONTINUED OPERATIONS BEFORE TAXES
|
247
|
|
|
(561
|
)
|
||
|
Income tax expense
|
—
|
|
|
—
|
|
||
|
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS, NET OF TAX
|
247
|
|
|
(561
|
)
|
||
|
Loss from disposal of discontinued operations
|
—
|
|
|
—
|
|
||
|
TOTAL INCOME (LOSS) FROM DISCONTINUED OPERATIONS
|
$
|
247
|
|
|
$
|
(561
|
)
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
ASSETS
|
|
|
|
||||
|
Restricted cash
|
$
|
138
|
|
|
$
|
138
|
|
|
Accrued interest receivable
|
33
|
|
|
67
|
|
||
|
Loans held for sale
|
59,320
|
|
|
93,063
|
|
||
|
Property available-for-sale
|
117
|
|
|
—
|
|
||
|
Principal paydowns receivable
|
14,827
|
|
|
—
|
|
||
|
Other assets
(1)
|
3,186
|
|
|
14,450
|
|
||
|
Total assets held for sale
|
$
|
77,621
|
|
|
$
|
107,718
|
|
|
|
|
|
|
||||
|
LIABILITIES
|
|
|
|
||||
|
Accounts payable and other liabilities
|
$
|
2,883
|
|
|
$
|
10,283
|
|
|
Management fee payable
|
—
|
|
|
56
|
|
||
|
Accrued interest payable
|
—
|
|
|
3
|
|
||
|
Total liabilities held for sale
|
$
|
2,883
|
|
|
$
|
10,342
|
|
|
(1)
|
Includes the Company's investment in life settlement contracts of
$177,000
and
$5.1 million
at
March 31, 2018
and
December 31, 2017
, respectively, which were transferred to held for sale in the fourth quarter of 2016.
|
|
Loan Description
|
|
Number of Loans
|
|
Amortized Cost
|
|
Carrying Value
|
||||
|
At March 31, 2018:
|
|
|
|
|
|
|
||||
|
Legacy CRE whole loans
|
|
4
|
|
$
|
63,882
|
|
|
$
|
57,341
|
|
|
Mezzanine loans
(1)
|
|
1
|
|
—
|
|
|
—
|
|
||
|
Middle market loans
(2)
|
|
1
|
|
13,837
|
|
|
1,979
|
|
||
|
Total loans held for sale
|
|
6
|
|
$
|
77,719
|
|
|
$
|
59,320
|
|
|
|
|
|
|
|
|
|
||||
|
At December 31, 2017:
|
|
|
|
|
|
|
||||
|
Legacy CRE whole loans
|
|
5
|
|
$
|
63,783
|
|
|
$
|
61,841
|
|
|
Mezzanine loans
(1)
|
|
1
|
|
—
|
|
|
—
|
|
||
|
Middle market loans
(2)
|
|
5
|
|
41,199
|
|
|
29,308
|
|
||
|
Residential mortgage loans
(3)(4)(5)
|
|
14
|
|
1,914
|
|
|
1,914
|
|
||
|
Total loans held for sale
|
|
25
|
|
$
|
106,896
|
|
|
$
|
93,063
|
|
|
(1)
|
Includes a mezzanine loan with a par value of
$38.1 million
that was acquired at a fair value of
zero
as a result of the liquidations of Resource Real Estate Funding CDO 2006-1, Ltd. in April 2016 and Resource Real Estate Funding CDO 2007-1, Ltd. in November 2016. The mezzanine loan is comprised of
two
tranches, maturing in November 2018 and September 2021.
|
|
(2)
|
Includes a directly originated middle market loan with fair values of
$2.0 million
and
$2.0 million
at
March 31, 2018
and
December 31, 2017
, respectively. At
March 31, 2018
, the loan is current w
ith the terms of a forbearance agreement, extending the loan to allow for the borrower to seek a sale of its business.
The loan's fair value was supported by a third party valuation mark prepared at
December 31, 2017
, which the Company relied on at
March 31, 2018
.
|
|
(3)
|
The fair value option was elected for residential mortgage loans held for sale.
|
|
(4)
|
The Company's residential mortgage loan portfolio was comprised of both agency loans and non-agency jumbo loans. The fair values of the agency loan portfolio were generally classified as Level 2 in the fair value hierarchy, as those values are determined based on quoted market prices for similar assets or upon other observable inputs. The fair values of the jumbo loan portfolio were generally classified as Level 3 in the fair value hierarchy, as those values are generally based upon valuation techniques that utilize unobservable inputs that reflect the assumptions that a market participant would use in pricing those assets.
|
|
ITEM 2 .
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
•
|
First mortgage loans, which we refer to as whole loans. These loans are typically secured by first liens on CRE property, including the following property types: office, multifamily, self-storage, retail, hotel, healthcare, student housing, manufactured housing, industrial and mixed-use.
|
|
•
|
First priority interests in first mortgage loans, which we refer to as A-Notes. The A-Note is typically a privately negotiated loan that is secured by a first mortgage on a commercial property or group of related properties that is senior to a B-Note secured by the same first mortgage property or group.
|
|
•
|
Subordinated interests in first mortgage loans, which we refer to as B-Notes. A B-Note is typically a privately negotiated loan that is secured by a first mortgage on a commercial property or group of related properties and is subordinated to an A-Note secured by the same first mortgage property or group. B-Notes are subject to more credit risk with respect to the underlying mortgage collateral than the corresponding A-Note.
|
|
•
|
Mezzanine debt that is senior to borrower's equity but is subordinated to other third-party debt. Like B-Notes, these loans are also subordinated CRE loans, but are usually secured by a pledge of the borrower's equity ownership in the entity that owns the property or by a second lien mortgage on the property.
|
|
•
|
Preferred equity investments that are subordinate to first mortgage loans and mezzanine debt. These investments may be subject to more credit risk than subordinated debt but provide the potential for higher returns upon a liquidation of the underlying property and are typically structured to provide some credit enhancement differentiating it from the common equity in such investments.
|
|
•
|
Commercial mortgage-backed securities, which we refer to as CMBS, that are collateralized by commercial mortgage loans, including senior and subordinated investment grade CMBS, below investment grade CMBS and unrated CMBS.
|
|
•
|
Other CRE Investments: We may invest in other income producing real estate debt and equity investments.
|
|
|
Identified Assets at Plan Inception
|
|
Impairments/Adjustments on Non-Monetized Assets
(1)(2)
|
|
Impairments/Adjustments on Monetized Assets
(1)
|
|
Monetized through March 31, 2018
(3)
|
|
Net Book Value at March 31, 2018
(3)
|
||||||||||
|
Discontinued operations and assets held for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Legacy CRE loans
(4)
|
$
|
194.7
|
|
|
$
|
(18.3
|
)
|
|
$
|
(11.7
|
)
|
|
$
|
(107.4
|
)
|
|
$
|
57.3
|
|
|
Middle market loans
|
73.8
|
|
|
(17.0
|
)
|
|
(0.8
|
)
|
|
(54.0
|
)
|
|
2.0
|
|
|||||
|
Residential mortgage lending segment
(5)
|
56.6
|
|
|
(1.7
|
)
|
|
(9.6
|
)
|
|
(43.7
|
)
|
|
1.6
|
|
|||||
|
Other assets held for sale
|
5.9
|
|
|
—
|
|
|
3.9
|
|
|
(8.9
|
)
|
|
0.9
|
|
|||||
|
Subtotal - discontinued operations and assets held for sale
|
331.0
|
|
|
(37.0
|
)
|
|
(18.2
|
)
|
|
(214.0
|
)
|
|
61.8
|
|
|||||
|
Investments in unconsolidated entities
|
86.6
|
|
|
—
|
|
|
38.3
|
|
|
(124.3
|
)
|
|
0.6
|
|
|||||
|
Commercial finance assets
|
62.5
|
|
|
—
|
|
|
—
|
|
|
(62.3
|
)
|
|
0.2
|
|
|||||
|
Total
|
$
|
480.1
|
|
|
$
|
(37.0
|
)
|
|
$
|
20.1
|
|
|
$
|
(400.6
|
)
|
|
$
|
62.6
|
|
|
(1)
|
Reflects adjustments as a result of the designation as assets held for sale or discontinued operations, which occurred during the third and fourth quarters of 2016 except as noted in (2) below.
|
|
(2)
|
The impairment adjustment to middle market loans includes
$5.4 million
of fair value adjustments that occurred prior to the inception of the Plan.
|
|
(3)
|
Residential mortgage lending segment and investments in unconsolidated entities include pro forma adjustments of
$3.6 million
and
$4.3 million
, respectively, for proceeds received in April 2018. Middle market loans include pro forma adjustments of
$14.8 million
for proceeds received in May 2018.
|
|
(4)
|
Legacy CRE loans include
$118.2 million
par value of loans at the inception of the Plan that were not reflected on the consolidated balance sheets until our investment in Resource Real Estate Funding CDO 2007-1, Ltd. ("RREF CDO 2007-1") was liquidated in November 2016.
|
|
(5)
|
Includes
$1.9 million
of cash and cash equivalents not classified as assets held for sale in the residential mortgage lending segment at
March 31, 2018
.
|
|
|
|
Three Months Ended March 31, 2018 Compared to Three Months Ended March 31, 2017
|
||||||||||
|
|
|
|
|
Due to Changes in
|
||||||||
|
|
|
Net Change
|
|
Volume
|
|
Rate
|
||||||
|
Increase (decrease) in interest income:
|
|
|
|
|
|
|
||||||
|
CRE loans
|
|
$
|
850
|
|
|
$
|
(404
|
)
|
|
$
|
1,254
|
|
|
Securities
|
|
1,148
|
|
|
1,982
|
|
|
(834
|
)
|
|||
|
Other
|
|
(1,512
|
)
|
|
(1,512
|
)
|
|
—
|
|
|||
|
Total increase (decrease) in interest income
|
|
486
|
|
|
66
|
|
|
420
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Increase (decrease) in interest expense:
|
|
|
|
|
|
|
||||||
|
Securitized borrowings:
|
|
|
|
|
|
|
||||||
|
RCC 2014-CRE2 Senior Notes
|
|
(1,430
|
)
|
|
(1,430
|
)
|
|
—
|
|
|||
|
RCC 2015-CRE3 Senior Notes
|
|
(903
|
)
|
|
(1,564
|
)
|
|
661
|
|
|||
|
RCC 2015-CRE4 Senior Notes
|
|
(907
|
)
|
|
(1,306
|
)
|
|
399
|
|
|||
|
RCC 2017-CRE5 Senior Notes
|
|
1,857
|
|
|
1,857
|
|
|
—
|
|
|||
|
Unsecured Junior Subordinated Debentures
|
|
84
|
|
|
—
|
|
|
84
|
|
|||
|
Convertible senior notes:
|
|
|
|
|
|
|
||||||
|
4.50% Convertible Senior Notes
|
|
2,365
|
|
|
2,365
|
|
|
—
|
|
|||
|
6.00% Convertible Senior Notes
|
|
(835
|
)
|
|
(835
|
)
|
|
—
|
|
|||
|
8.00% Convertible Senior Notes
|
|
(1,804
|
)
|
|
(1,804
|
)
|
|
—
|
|
|||
|
CRE - Term Repurchase Facilities
|
|
471
|
|
|
(235
|
)
|
|
706
|
|
|||
|
CMBS - Term Repurchase Facilities
|
|
(279
|
)
|
|
(407
|
)
|
|
128
|
|
|||
|
Trust Certificates - Term Repurchase Facilities
|
|
755
|
|
|
768
|
|
|
(13
|
)
|
|||
|
CMBS - Short Term Repurchase Agreements
|
|
723
|
|
|
723
|
|
|
—
|
|
|||
|
Hedging
|
|
33
|
|
|
33
|
|
|
—
|
|
|||
|
Total increase (decrease) in interest expense
|
|
130
|
|
|
(1,835
|
)
|
|
1,965
|
|
|||
|
Net increase (decrease) in net interest income
|
|
$
|
356
|
|
|
$
|
1,901
|
|
|
$
|
(1,545
|
)
|
|
|
|
For the Three Months Ended March 31, 2018
|
|
For the Three Months Ended March 31, 2017
|
||||||||||||||||||
|
|
|
Average Balance
|
|
Interest Income (Expense)
|
|
Average Net Yield (Cost of Funds)
|
|
Average Balance
|
|
Interest Income (Expense)
|
|
Average Net Yield (Cost of Funds)
|
||||||||||
|
Interest-earning assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
CRE loans
|
|
$
|
1,393,729
|
|
|
$
|
22,383
|
|
|
6.49
|
%
|
|
$
|
1,466,259
|
|
|
$
|
21,533
|
|
|
5.94
|
%
|
|
Securities
|
|
216,870
|
|
|
3,456
|
|
|
6.51
|
%
|
|
102,065
|
|
|
2,308
|
|
|
7.20
|
%
|
||||
|
Other
|
|
25,156
|
|
|
118
|
|
|
0.48
|
%
|
|
50,655
|
|
|
1,630
|
|
|
12.90
|
%
|
||||
|
Total interest income/average net yield
|
|
1,635,755
|
|
|
25,957
|
|
|
6.40
|
%
|
|
1,618,979
|
|
|
25,471
|
|
|
6.24
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Interest-bearing liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Collateralized by:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
CRE whole loans
|
|
685,064
|
|
|
(7,260
|
)
|
|
(4.30
|
)%
|
|
830,089
|
|
|
(8,172
|
)
|
|
(3.99
|
)%
|
||||
|
CMBS
|
|
118,783
|
|
|
(987
|
)
|
|
(3.37
|
)%
|
|
76,623
|
|
|
(543
|
)
|
|
(2.87
|
)%
|
||||
|
General corporate debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Unsecured Junior Subordinated Debentures
|
|
51,548
|
|
|
(724
|
)
|
|
(5.62
|
)%
|
|
51,548
|
|
|
(640
|
)
|
|
(4.94
|
)%
|
||||
|
4.50% Convertible Senior Notes
|
|
143,750
|
|
|
(2,365
|
)
|
|
(6.58
|
)%
|
|
—
|
|
|
—
|
|
|
—
|
%
|
||||
|
6.00% Convertible Senior Notes
|
|
70,453
|
|
|
(1,308
|
)
|
|
(7.42
|
)%
|
|
115,000
|
|
|
(2,143
|
)
|
|
(7.46
|
)%
|
||||
|
8.00% Convertible Senior Notes
|
|
21,182
|
|
|
(480
|
)
|
|
(9.07
|
)%
|
|
100,000
|
|
|
(2,284
|
)
|
|
(9.14
|
)%
|
||||
|
Trust Certificates - Term Repurchase Facilities
|
|
74,419
|
|
|
(1,210
|
)
|
|
(6.59
|
)%
|
|
26,598
|
|
|
(455
|
)
|
|
(6.93
|
)%
|
||||
|
Hedging
|
|
42,189
|
|
|
(50
|
)
|
|
(0.48
|
)%
|
|
—
|
|
|
(17
|
)
|
|
—
|
%
|
||||
|
Total interest expense/average cost of funds
|
|
$
|
1,207,388
|
|
|
(14,384
|
)
|
|
(4.81
|
)%
|
|
$
|
1,199,858
|
|
|
(14,254
|
)
|
|
(4.79
|
)%
|
||
|
Total net interest income/average spread
|
|
|
|
$
|
11,573
|
|
|
1.59
|
%
|
|
|
|
$
|
11,217
|
|
|
1.45
|
%
|
||||
|
|
|
For the Three Months Ended
|
|
For the Three Months Ended
|
||||||||
|
|
|
March 31, 2018
|
|
March 31, 2017
|
||||||||
|
|
|
Weighted Average
|
|
Weighted Average
|
||||||||
|
|
|
Yield
(1)
|
|
Balance
|
|
Yield
(1)
|
|
Balance
|
||||
|
Interest income:
|
|
|
|
|
|
|
|
|
||||
|
Interest income from loans:
|
|
|
|
|
|
|
|
|
||||
|
CRE whole loans
|
|
6.76%
|
|
$
|
1,317,026
|
|
|
6.37%
|
|
$
|
1,282,763
|
|
|
Legacy CRE loans held for sale
|
|
1.71%
|
|
$
|
76,063
|
|
|
2.93%
|
|
$
|
183,496
|
|
|
CRE preferred equity investment
|
|
11.66%
|
|
$
|
640
|
|
|
—%
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Interest income from securities:
|
|
|
|
|
|
|
|
|
||||
|
CMBS
|
|
6.51%
|
|
$
|
216,764
|
|
|
6.77%
|
|
$
|
96,118
|
|
|
ABS
|
|
0.02%
|
|
$
|
106
|
|
|
16.95%
|
|
$
|
4,492
|
|
|
RMBS
|
|
—%
|
|
$
|
—
|
|
|
5.44%
|
|
$
|
1,455
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Preference payments on structured notes
|
|
—%
|
|
$
|
—
|
|
|
10.88%
|
|
$
|
17,541
|
|
|
Preference payments on trading securities
|
|
0.04%
|
|
$
|
3,541
|
|
|
107.29%
|
|
$
|
4,286
|
|
|
(1)
|
The weighted average yield includes net amortization/accretion and fee income in the calculation.
|
|
|
|
Type of Investment
|
|
Weighted Average Coupon Interest
|
|
Unamortized (Discount) Premium
|
|
Net Amortization/Accretion
|
|
Interest Income
|
|
Fee Income
(1)
|
|
Total
|
|||||||||||
|
For the Three Months Ended March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
CRE whole loans
|
|
6.27
|
%
|
|
$
|
(7,425
|
)
|
|
$
|
—
|
|
|
$
|
20,568
|
|
|
$
|
1,382
|
|
|
$
|
21,950
|
|
|
Legacy CRE loans held for sale
|
|
1.70
|
%
|
|
$
|
—
|
|
|
—
|
|
|
322
|
|
|
—
|
|
|
322
|
|
||||
|
CRE preferred equity investment
|
|
11.50
|
%
|
|
$
|
—
|
|
|
—
|
|
|
18
|
|
|
—
|
|
|
18
|
|
||||
|
Syndicated corporate loans
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
|
|
2
|
|
|
91
|
|
|
93
|
|
||||
|
Total interest income from loans
|
|
|
|
|
|
—
|
|
|
20,910
|
|
|
1,473
|
|
|
22,383
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
CMBS
|
|
4.43
|
%
|
|
$
|
(40,143
|
)
|
|
641
|
|
|
2,815
|
|
|
—
|
|
|
3,456
|
|
||||
|
Total interest income from securities
|
|
|
|
|
|
641
|
|
|
2,815
|
|
|
—
|
|
|
3,456
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Other
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
|
|
118
|
|
|
—
|
|
|
118
|
|
||||
|
Total interest income - other
|
|
|
|
|
|
—
|
|
|
118
|
|
|
—
|
|
|
118
|
|
|||||||
|
Total interest income
|
|
|
|
|
|
$
|
641
|
|
|
$
|
23,843
|
|
|
$
|
1,473
|
|
|
$
|
25,957
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
For the Three Months Ended March 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
CRE whole loans
|
|
5.76
|
%
|
|
$
|
(5,921
|
)
|
|
$
|
(2
|
)
|
|
$
|
18,283
|
|
|
$
|
1,883
|
|
|
$
|
20,164
|
|
|
Legacy CRE loans held for sale
|
|
2.58
|
%
|
|
$
|
—
|
|
|
—
|
|
|
1,323
|
|
|
—
|
|
|
1,323
|
|
||||
|
Syndicated corporate loans
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
|
|
46
|
|
|
—
|
|
|
46
|
|
||||
|
Total interest income from loans
|
|
|
|
|
|
(2
|
)
|
|
19,652
|
|
|
1,883
|
|
|
21,533
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
CMBS
|
|
5.30
|
%
|
|
$
|
(1,064
|
)
|
|
202
|
|
|
1,875
|
|
|
—
|
|
|
2,077
|
|
||||
|
ABS
|
|
10.10
|
%
|
|
$
|
—
|
|
|
—
|
|
|
212
|
|
|
—
|
|
|
212
|
|
||||
|
RMBS
|
|
3.58
|
%
|
|
$
|
35
|
|
|
—
|
|
|
19
|
|
|
—
|
|
|
19
|
|
||||
|
Total interest income from securities
|
|
|
|
|
|
202
|
|
|
2,106
|
|
|
—
|
|
|
2,308
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Preference payments on structured notes
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
|
|
470
|
|
|
—
|
|
|
470
|
|
||||
|
Preference payments on trading securities
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
|
|
1,134
|
|
|
—
|
|
|
1,134
|
|
||||
|
Other
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
|
|
26
|
|
|
—
|
|
|
26
|
|
||||
|
Total interest income - other
|
|
|
|
|
|
—
|
|
|
1,630
|
|
|
—
|
|
|
1,630
|
|
|||||||
|
Total interest income
|
|
|
|
|
|
$
|
200
|
|
|
$
|
23,388
|
|
|
$
|
1,883
|
|
|
$
|
25,471
|
|
|||
|
(1)
|
Fee income recognized as a component of interest income is primarily comprised of loan origination fees, loan exit fees and loan extension fees.
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|||||||||
|
|
|
March 31,
|
|
|
|
|
|||||||||
|
|
|
2018
|
|
2017
|
|
Dollar Change
|
|
Percent Change
|
|||||||
|
Interest income:
|
|
|
|
|
|
|
|
|
|||||||
|
Interest income from loans:
|
|
|
|
|
|
|
|
|
|||||||
|
CRE whole loans
|
|
$
|
21,950
|
|
|
$
|
20,164
|
|
|
$
|
1,786
|
|
|
9
|
%
|
|
Legacy CRE loans held for sale
|
|
322
|
|
|
1,323
|
|
|
(1,001
|
)
|
|
(76
|
)%
|
|||
|
CRE preferred equity investment
|
|
18
|
|
|
—
|
|
|
18
|
|
|
100
|
%
|
|||
|
Syndicated corporate loans
|
|
93
|
|
|
46
|
|
|
47
|
|
|
102
|
%
|
|||
|
Total interest income from loans
|
|
22,383
|
|
|
21,533
|
|
|
850
|
|
|
4
|
%
|
|||
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Interest income from securities:
|
|
|
|
|
|
|
|
|
|
||||||
|
CMBS
|
|
3,456
|
|
|
2,077
|
|
|
1,379
|
|
|
66
|
%
|
|||
|
ABS
|
|
—
|
|
|
212
|
|
|
(212
|
)
|
|
(100
|
)%
|
|||
|
RMBS
|
|
—
|
|
|
19
|
|
|
(19
|
)
|
|
(100
|
)%
|
|||
|
Total interest income from securities
|
|
3,456
|
|
|
2,308
|
|
|
1,148
|
|
|
50
|
%
|
|||
|
|
|
|
|
|
|
|
|
|
|||||||
|
Interest income - other:
|
|
|
|
|
|
|
|
|
|||||||
|
Preference payments on structured notes
|
|
—
|
|
|
470
|
|
|
(470
|
)
|
|
(100
|
)%
|
|||
|
Preference payments on trading securities
|
|
—
|
|
|
1,134
|
|
|
(1,134
|
)
|
|
(100
|
)%
|
|||
|
Other
|
|
118
|
|
|
26
|
|
|
92
|
|
|
354
|
%
|
|||
|
Total interest income - other
|
|
118
|
|
|
1,630
|
|
|
(1,512
|
)
|
|
(93
|
)%
|
|||
|
Total interest income
|
|
$
|
25,957
|
|
|
$
|
25,471
|
|
|
$
|
486
|
|
|
2
|
%
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Three Months Ended
|
||||||||||
|
|
|
March 31, 2018
|
|
March 31, 2017
|
||||||||||
|
|
|
Weighted Average
|
|
Weighted Average
|
||||||||||
|
|
|
Cost of Funds
|
|
Balance
|
|
Cost of Funds
|
|
Balance
|
||||||
|
Interest expense:
|
|
|
|
|
|
|
|
|
||||||
|
CRE whole loans
|
|
4.30
|
%
|
|
$
|
685,064
|
|
|
3.99
|
%
|
|
$
|
830,089
|
|
|
Convertible senior notes
|
|
7.06
|
%
|
|
$
|
235,385
|
|
|
8.24
|
%
|
|
$
|
215,000
|
|
|
CMBS
|
|
3.37
|
%
|
|
$
|
118,783
|
|
|
2.87
|
%
|
|
$
|
76,623
|
|
|
Unsecured junior subordinated debentures / other
|
|
5.62
|
%
|
|
$
|
51,548
|
|
|
4.94
|
%
|
|
$
|
51,548
|
|
|
Trust certificates
|
|
6.59
|
%
|
|
$
|
74,419
|
|
|
6.93
|
%
|
|
$
|
26,598
|
|
|
Hedging
|
|
0.48
|
%
|
|
$
|
42,189
|
|
|
—
|
%
|
|
$
|
—
|
|
|
|
|
Type of Security
|
|
Coupon Interest
|
|
Unamortized Deferred Debt Expense
|
|
Net Amortization
|
|
Interest Expense
|
|
Total
|
|||||||||
|
For the Three Months Ended March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
CRE whole loans
|
|
3.57
|
%
|
|
$
|
4,340
|
|
|
$
|
969
|
|
|
$
|
6,291
|
|
|
$
|
7,260
|
|
|
Convertible senior notes
|
|
5.26
|
%
|
|
$
|
16,964
|
|
|
1,056
|
|
|
3,097
|
|
|
4,153
|
|
|||
|
CMBS
|
|
3.09
|
%
|
|
$
|
—
|
|
|
—
|
|
|
987
|
|
|
987
|
|
|||
|
Unsecured junior subordinated debentures / other
|
|
5.62
|
%
|
|
$
|
—
|
|
|
—
|
|
|
724
|
|
|
724
|
|
|||
|
Trust certificates
|
|
6.10
|
%
|
|
$
|
494
|
|
|
76
|
|
|
1,134
|
|
|
1,210
|
|
|||
|
Hedging
(1)
|
|
0.49
|
%
|
|
$
|
—
|
|
|
—
|
|
|
50
|
|
|
50
|
|
|||
|
Total interest expense
|
|
|
|
|
|
$
|
2,101
|
|
|
$
|
12,283
|
|
|
$
|
14,384
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
For the Three Months Ended March 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
CRE whole loans
|
|
2.90
|
%
|
|
$
|
7,083
|
|
|
$
|
2,019
|
|
|
$
|
6,153
|
|
|
$
|
8,172
|
|
|
Convertible senior notes
|
|
6.93
|
%
|
|
$
|
6,001
|
|
|
702
|
|
|
3,725
|
|
|
4,427
|
|
|||
|
CMBS
|
|
2.75
|
%
|
|
$
|
7
|
|
|
10
|
|
|
533
|
|
|
543
|
|
|||
|
Unsecured junior subordinated debentures / other
|
|
4.94
|
%
|
|
$
|
—
|
|
|
—
|
|
|
640
|
|
|
640
|
|
|||
|
Trust certificates
|
|
6.29
|
%
|
|
$
|
245
|
|
|
37
|
|
|
418
|
|
|
455
|
|
|||
|
Hedging
(1)
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
|
|
17
|
|
|
17
|
|
|||
|
Total interest expense
|
|
|
|
|
|
$
|
2,768
|
|
|
$
|
11,486
|
|
|
$
|
14,254
|
|
|||
|
(1)
|
Hedging coupon interest is calculated as the net of the fixed pay rate and floating rate received.
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|||||||||
|
|
|
March 31,
|
|
|
|
|
|||||||||
|
|
|
2018
|
|
2017
|
|
Dollar Change
|
|
Percent Change
|
|||||||
|
Interest expense:
|
|
|
|
|
|
|
|
|
|||||||
|
CRE whole loans
|
|
$
|
7,260
|
|
|
$
|
8,172
|
|
|
$
|
(912
|
)
|
|
(11
|
)%
|
|
Convertible senior notes
|
|
4,153
|
|
|
4,427
|
|
|
(274
|
)
|
|
(6
|
)%
|
|||
|
CMBS
|
|
987
|
|
|
543
|
|
|
444
|
|
|
82
|
%
|
|||
|
Unsecured junior subordinated debentures / other
|
|
724
|
|
|
640
|
|
|
84
|
|
|
13
|
%
|
|||
|
Trust certificates
|
|
1,210
|
|
|
455
|
|
|
755
|
|
|
166
|
%
|
|||
|
Hedging
|
|
50
|
|
|
17
|
|
|
33
|
|
|
194
|
%
|
|||
|
Total interest expense
|
|
$
|
14,384
|
|
|
$
|
14,254
|
|
|
$
|
130
|
|
|
1
|
%
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|||||||||
|
|
|
March 31,
|
|
|
|
|
|||||||||
|
|
|
2018
|
|
2017
|
|
Dollar Change
|
|
Percent Change
|
|||||||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|||||||
|
General and administrative
|
|
$
|
3,060
|
|
|
$
|
3,863
|
|
|
$
|
(803
|
)
|
|
(21
|
)%
|
|
Management fees
|
|
2,813
|
|
|
2,680
|
|
|
133
|
|
|
5
|
%
|
|||
|
Equity compensation
|
|
967
|
|
|
788
|
|
|
179
|
|
|
23
|
%
|
|||
|
Depreciation and amortization
|
|
13
|
|
|
68
|
|
|
(55
|
)
|
|
(81
|
)%
|
|||
|
Impairment losses
|
|
—
|
|
|
177
|
|
|
(177
|
)
|
|
(100
|
)%
|
|||
|
(Recovery of) provision for loan and lease losses, net
|
|
(799
|
)
|
|
999
|
|
|
(1,798
|
)
|
|
(180
|
)%
|
|||
|
Total operating expenses
|
|
$
|
6,054
|
|
|
$
|
8,575
|
|
|
$
|
(2,521
|
)
|
|
(29
|
)%
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|||||||||
|
|
|
March 31,
|
|
|
|
|
|||||||||
|
|
|
2018
|
|
2017
|
|
Dollar Change
|
|
Percent Change
|
|||||||
|
General and administrative:
|
|
|
|
|
|
|
|
|
|||||||
|
Professional services
|
|
$
|
1,028
|
|
|
$
|
1,628
|
|
|
$
|
(600
|
)
|
|
(37
|
)%
|
|
Wages and benefits
|
|
1,035
|
|
|
788
|
|
|
247
|
|
|
31
|
%
|
|||
|
D&O insurance
|
|
310
|
|
|
196
|
|
|
114
|
|
|
58
|
%
|
|||
|
Dues and subscriptions
|
|
219
|
|
|
288
|
|
|
(69
|
)
|
|
(24
|
)%
|
|||
|
Operating expenses
|
|
198
|
|
|
410
|
|
|
(212
|
)
|
|
(52
|
)%
|
|||
|
Director fees
|
|
164
|
|
|
249
|
|
|
(85
|
)
|
|
(34
|
)%
|
|||
|
Rent and utilities
|
|
78
|
|
|
156
|
|
|
(78
|
)
|
|
(50
|
)%
|
|||
|
Travel
|
|
61
|
|
|
103
|
|
|
(42
|
)
|
|
(41
|
)%
|
|||
|
Tax penalties, interest and franchise tax
|
|
(33
|
)
|
|
45
|
|
|
(78
|
)
|
|
(173
|
)%
|
|||
|
Total general and administrative
|
|
$
|
3,060
|
|
|
$
|
3,863
|
|
|
$
|
(803
|
)
|
|
(21
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
|
|
|||||||||
|
|
|
March 31,
|
|
|
|
|
|||||||||
|
|
|
2018
|
|
2017
|
|
Dollar Change
|
|
Percent Change
|
|||||||
|
Other Income (Expense):
|
|
|
|
|
|
|
|
|
|
||||||
|
Equity in (losses) earnings of unconsolidated entities
|
|
$
|
(292
|
)
|
|
$
|
361
|
|
|
$
|
(653
|
)
|
|
(181
|
)%
|
|
Net realized and unrealized (loss) gain on investment securities available-for-sale and loans and derivatives
|
|
(642
|
)
|
|
7,606
|
|
|
(8,248
|
)
|
|
(108
|
)%
|
|||
|
Net realized and unrealized loss on investment securities, trading
|
|
(5
|
)
|
|
(911
|
)
|
|
906
|
|
|
99
|
%
|
|||
|
Fair value adjustments on financial assets held for sale
|
|
(4,665
|
)
|
|
(21
|
)
|
|
(4,644
|
)
|
|
(22,114
|
)%
|
|||
|
Other income
|
|
11
|
|
|
68
|
|
|
(57
|
)
|
|
(84
|
)%
|
|||
|
Total other (expense) income
|
|
$
|
(5,593
|
)
|
|
$
|
7,103
|
|
|
$
|
(12,696
|
)
|
|
(179
|
)%
|
|
|
|
|
For the Three Months Ended
|
||||||
|
|
March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
REVENUES
|
|
|
|
||||
|
Interest income:
|
|
|
|
||||
|
Loans
|
$
|
570
|
|
|
$
|
897
|
|
|
Other
|
4
|
|
|
13
|
|
||
|
Total interest income
|
574
|
|
|
910
|
|
||
|
Interest expense
|
—
|
|
|
—
|
|
||
|
Net interest income
|
574
|
|
|
910
|
|
||
|
Gain (loss) on sale of residential mortgage loans
|
(14
|
)
|
|
3,825
|
|
||
|
Fee income (loss)
|
99
|
|
|
2,180
|
|
||
|
Total revenues
|
659
|
|
|
6,915
|
|
||
|
OPERATING EXPENSES
|
|
|
|
||||
|
Equity compensation
|
—
|
|
|
59
|
|
||
|
General and administrative
|
660
|
|
|
7,473
|
|
||
|
Total operating expenses
|
660
|
|
|
7,532
|
|
||
|
|
|
|
|
||||
|
|
(1
|
)
|
|
(617
|
)
|
||
|
OTHER INCOME (EXPENSE)
|
|
|
|
||||
|
Net realized and unrealized (loss) gain on investment securities available-for-sale and loans and derivatives
|
248
|
|
|
(2
|
)
|
||
|
Fair value adjustments on financial assets held for sale
|
—
|
|
|
58
|
|
||
|
Total other (expense) income
|
248
|
|
|
56
|
|
||
|
|
|
|
|
||||
|
INCOME (LOSS) FROM DISCONTINUED OPERATIONS BEFORE TAXES
|
247
|
|
|
(561
|
)
|
||
|
Income tax expense
|
—
|
|
|
—
|
|
||
|
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS, NET OF TAX
|
247
|
|
|
(561
|
)
|
||
|
Loss from disposal of discontinued operations
|
—
|
|
|
—
|
|
||
|
TOTAL INCOME (LOSS) FROM DISCONTINUED OPERATIONS
|
$
|
247
|
|
|
$
|
(561
|
)
|
|
At March 31, 2018
|
|
Amortized
Cost |
|
Net Carrying Amount
|
|
Percent of
Portfolio |
|
Weighted
Average Coupon |
|||||
|
Loans held for investment:
|
|
|
|
|
|
|
|
|
|||||
|
CRE whole loans
(1)
|
|
$
|
1,362,520
|
|
|
$
|
1,357,991
|
|
|
80.16
|
%
|
|
6.34%
|
|
CRE preferred equity investment
|
|
19,008
|
|
|
19,008
|
|
|
1.12
|
%
|
|
11.50%
|
||
|
|
|
1,381,528
|
|
|
1,376,999
|
|
|
81.28
|
%
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Investment securities available-for-sale:
|
|
|
|
|
|
|
|
|
|||||
|
CMBS
|
|
251,343
|
|
|
250,746
|
|
|
14.80
|
%
|
|
4.36%
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Investment securities, trading:
|
|
|
|
|
|
|
|
|
|||||
|
Structured notes
|
|
1,218
|
|
|
164
|
|
|
0.01
|
%
|
|
N/A
(6)
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Other investments:
|
|
|
|
|
|
|
|
|
|||||
|
Investments in unconsolidated entities
|
|
6,439
|
|
|
6,439
|
|
|
0.38
|
%
|
|
N/A
(6)
|
||
|
Direct financing leases
(3)
|
|
824
|
|
|
89
|
|
|
0.01
|
%
|
|
5.66%
|
||
|
|
|
7,263
|
|
|
6,528
|
|
|
0.39
|
%
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Other assets held for sale:
|
|
|
|
|
|
|
|
|
|||||
|
Legacy CRE loans
(4)
|
|
63,882
|
|
|
57,341
|
|
|
3.38
|
%
|
|
1.71%
|
||
|
Middle market loan
(5)
|
|
13,837
|
|
|
1,978
|
|
|
0.12
|
%
|
|
—%
|
||
|
Life settlement contracts
|
|
177
|
|
|
177
|
|
|
0.01
|
%
|
|
N/A
(6)
|
||
|
Property available-for-sale
|
|
117
|
|
|
117
|
|
|
0.01
|
%
|
|
N/A
(6)
|
||
|
|
|
78,013
|
|
|
59,613
|
|
|
3.52
|
%
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Total investment portfolio
|
|
$
|
1,719,365
|
|
|
$
|
1,694,050
|
|
|
100.00
|
%
|
|
|
|
At December 31, 2017
|
|
Amortized
Cost |
|
Net Carrying Amount
|
|
Percent of
Portfolio |
|
Weighted
Average Coupon |
|||||
|
Loans held for investment:
|
|
|
|
|
|
|
|
|
|||||
|
CRE whole loans
(1)
|
|
$
|
1,290,150
|
|
|
$
|
1,284,822
|
|
|
79.94
|
%
|
|
6.09%
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Investment securities available-for-sale:
|
|
|
|
|
|
|
|
|
|||||
|
CMBS
|
|
210,806
|
|
|
211,579
|
|
|
13.17
|
%
|
|
4.35%
|
||
|
ABS
|
|
259
|
|
|
158
|
|
|
0.01
|
%
|
|
N/A
(6)
|
||
|
|
|
211,065
|
|
|
211,737
|
|
|
13.18
|
%
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Investment securities, trading:
|
|
|
|
|
|
|
|
|
|||||
|
Structured notes
|
|
2,891
|
|
|
178
|
|
|
0.01
|
%
|
|
N/A
(6)
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Loans held for sale:
|
|
|
|
|
|
|
|
|
|||||
|
Syndicated corporate loans
(2)
|
|
13
|
|
|
13
|
|
|
—
|
%
|
|
N/A
(6)
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Other investments:
|
|
|
|
|
|
|
|
|
|||||
|
Investments in unconsolidated entities
|
|
12,051
|
|
|
12,051
|
|
|
0.75
|
%
|
|
N/A
(6)
|
||
|
Direct financing leases
(3)
|
|
886
|
|
|
151
|
|
|
0.01
|
%
|
|
5.66%
|
||
|
|
|
12,937
|
|
|
12,202
|
|
|
0.76
|
%
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Other assets held for sale:
|
|
|
|
|
|
|
|
|
|||||
|
Legacy CRE loans
(4)
|
|
63,783
|
|
|
61,841
|
|
|
3.85
|
%
|
|
1.64%
|
||
|
Middle market loans
(5)
|
|
41,199
|
|
|
29,308
|
|
|
1.82
|
%
|
|
5.06%
|
||
|
Life settlement contracts
|
|
5,130
|
|
|
5,130
|
|
|
0.32
|
%
|
|
N/A
(6)
|
||
|
Residential mortgage loans
|
|
1,913
|
|
|
1,913
|
|
|
0.12
|
%
|
|
3.92%
|
||
|
|
|
112,025
|
|
|
98,192
|
|
|
6.11
|
%
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Total investment portfolio
|
|
$
|
1,629,081
|
|
|
$
|
1,607,144
|
|
|
100.00
|
%
|
|
|
|
(1)
|
Net carrying amount includes an allowance for loan losses of
$4.5 million
and
$5.3 million
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(2)
|
The fair value option was elected for syndicated corporate loans held for sale.
|
|
(3)
|
Net carrying amount includes allowance for lease losses of
$735,000
and
$735,000
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(4)
|
Net carrying amount includes lower of cost or market value adjustments of
$6.5 million
and
$1.9 million
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(5)
|
Net carrying amount includes lower of cost or market value adjustments of
$11.9 million
and
$11.9 million
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(6)
|
There are no stated rates associated with these investments.
|
|
Description
|
|
Quantity
|
|
Principal
|
|
Unamortized (Discount)
Premium, net (1) |
|
Amortized Cost
|
|
Allowance for Loan Losses
|
|
Carrying
Value (2) |
|
Contracted Interest Rates
|
|
Maturity Dates
(3)(4)
|
||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
CRE loans held for investment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
(5)
|
|
75
|
|
$
|
1,369,753
|
|
|
$
|
(7,233
|
)
|
|
$
|
1,362,520
|
|
|
$
|
(4,529
|
)
|
|
$
|
1,357,991
|
|
|
1M LIBOR plus 3.50% to 1M LIBOR plus 6.25% (Floating) and 8.00% (Fixed)
|
|
April 2018 to April 2021
|
|
Preferred equity investment (see Note 3)
(6)(7)
|
|
1
|
|
19,200
|
|
|
(192
|
)
|
|
19,008
|
|
|
—
|
|
|
19,008
|
|
|
11.50%
|
|
April 2025
|
|||||
|
Total CRE loans held for investment
|
|
|
|
1,388,953
|
|
|
(7,425
|
)
|
|
1,381,528
|
|
|
(4,529
|
)
|
|
1,376,999
|
|
|
|
|
|
|||||
|
Total loans
|
|
|
|
$
|
1,388,953
|
|
|
$
|
(7,425
|
)
|
|
$
|
1,381,528
|
|
|
$
|
(4,529
|
)
|
|
$
|
1,376,999
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
CRE loans held for investment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
(5)
|
|
70
|
|
$
|
1,297,164
|
|
|
$
|
(7,014
|
)
|
|
$
|
1,290,150
|
|
|
$
|
(5,328
|
)
|
|
$
|
1,284,822
|
|
|
1M LIBOR plus 3.60% to 1M LIBOR plus 6.25%
|
|
February 2018 to January 2021
|
|
Total CRE loans held for investment
|
|
|
|
1,297,164
|
|
|
(7,014
|
)
|
|
1,290,150
|
|
|
(5,328
|
)
|
|
1,284,822
|
|
|
|
|
|
|||||
|
Syndicated corporate loans
(8)
|
|
2
|
|
13
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|
N/A
|
|
N/A
|
|||||
|
Total loans held for sale
|
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
13
|
|
|
|
|
|
|||||
|
Total loans
|
|
|
|
$
|
1,297,177
|
|
|
$
|
(7,014
|
)
|
|
$
|
1,290,163
|
|
|
$
|
(5,328
|
)
|
|
$
|
1,284,835
|
|
|
|
|
|
|
(1)
|
Amounts include unamortized loan origination fees of
$7.1 million
and
$6.7 million
and deferred amendment fees of
$368,000
and
$268,000
being amortized over the life of the loans at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(2)
|
Substantially all loans are pledged as collateral under various borrowings at
March 31, 2018
and
December 31, 2017
.
|
|
(3)
|
Maturity dates exclude contracted extension options, subject to the satisfaction of certain terms, that may be available to the borrowers.
|
|
(4)
|
Maturity dates exclude
one
CRE whole loan, with an amortized cost of
$7.0 million
, in default at
March 31, 2018
and
December 31, 2017
.
|
|
(5)
|
CRE whole loans had
$86.2 million
and
$84.1 million
in unfunded loan commitments at
March 31, 2018
and
December 31, 2017
, respectively. These unfunded commitments are advanced as the borrowers formally request additional funding, as permitted under the loan agreement, and any necessary approvals have been obtained.
|
|
(6)
|
The interest rate on the Company's preferred equity investment pays currently at
8.00%
. The remaining interest is deferred until maturity.
|
|
(7)
|
Beginning in April 2023, the Company has the right to unilaterally force the sale of the underlying property.
|
|
(8)
|
All syndicated corporate loans are second lien loans and are accounted for under the fair value option.
|
|
|
|
Fair Value at December 31, 2017
|
|
Net Purchases (Sales)
(1)
|
|
Net Upgrades (Downgrades)
|
|
Paydowns
|
|
MTM Change
on Same Ratings |
|
Fair Value at March 31, 2018
|
||||||||||||
|
Moody's ratings category:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Aaa
|
|
$
|
8,390
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(536
|
)
|
|
$
|
(128
|
)
|
|
$
|
7,726
|
|
|
Aa1 through Aa3
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
A1 through A3
|
|
1,563
|
|
|
—
|
|
|
—
|
|
|
(1,514
|
)
|
|
1
|
|
|
50
|
|
||||||
|
Baa1 through Baa3
|
|
8,432
|
|
|
—
|
|
|
—
|
|
|
(682
|
)
|
|
(5
|
)
|
|
7,745
|
|
||||||
|
Ba1 through Ba3
|
|
10,866
|
|
|
—
|
|
|
—
|
|
|
(79
|
)
|
|
(48
|
)
|
|
10,739
|
|
||||||
|
B1 through B3
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Caa1 through Caa3
|
|
426
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
424
|
|
||||||
|
Ca through C
|
|
191
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(44
|
)
|
|
147
|
|
||||||
|
Non-Rated
|
|
181,711
|
|
|
43,275
|
|
|
—
|
|
|
(568
|
)
|
|
(503
|
)
|
|
223,915
|
|
||||||
|
Total
|
|
$
|
211,579
|
|
|
$
|
43,275
|
|
|
$
|
—
|
|
|
$
|
(3,379
|
)
|
|
$
|
(729
|
)
|
|
$
|
250,746
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
S&P ratings category:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
AAA
|
|
$
|
1,318
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(55
|
)
|
|
$
|
(2
|
)
|
|
$
|
1,261
|
|
|
AA+ through AA-
|
|
4,371
|
|
|
—
|
|
|
—
|
|
|
(396
|
)
|
|
(19
|
)
|
|
3,956
|
|
||||||
|
A+ through A-
|
|
11,593
|
|
|
—
|
|
|
—
|
|
|
(1,551
|
)
|
|
(3
|
)
|
|
10,039
|
|
||||||
|
BBB+ through BBB-
|
|
22,502
|
|
|
—
|
|
|
—
|
|
|
(114
|
)
|
|
(43
|
)
|
|
22,345
|
|
||||||
|
BB+ through BB-
|
|
86,259
|
|
|
—
|
|
|
—
|
|
|
(670
|
)
|
|
(182
|
)
|
|
85,407
|
|
||||||
|
B+ through B-
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
CCC+ through CCC-
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
D
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Non-Rated
|
|
85,536
|
|
|
43,275
|
|
|
—
|
|
|
(593
|
)
|
|
(480
|
)
|
|
127,738
|
|
||||||
|
Total
|
|
$
|
211,579
|
|
|
$
|
43,275
|
|
|
$
|
—
|
|
|
$
|
(3,379
|
)
|
|
$
|
(729
|
)
|
|
$
|
250,746
|
|
|
(1)
|
During the
three months ended March 31, 2018
, we acquired
$4.0 million
of CMBS, at a cost of
$3.1 million
, with a weighted average spread, based on cost, of
3.20%
over the interpolated interest rate swap curve and
$40.3 million
of CMBS, at a cost of
$40.2 million
, with a weighted average spread, based on face value, of
2.32%
over LIBOR.
|
|
|
Fair Value at December 31, 2017
|
|
Net Purchases (Sales)
|
|
MTM Change
on Same Ratings |
|
Fair Value at March 31, 2018
|
||||||||
|
Moody's ratings category:
|
|
|
|
|
|
|
|
||||||||
|
Non-Rated
|
$
|
158
|
|
|
$
|
(259
|
)
|
|
$
|
101
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
S&P ratings category:
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Non-Rated
|
$
|
158
|
|
|
$
|
(259
|
)
|
|
$
|
101
|
|
|
$
|
—
|
|
|
|
|
Number of Securities
|
|
Amortized Cost
|
|
Unrealized Gains
|
|
Unrealized Losses
|
|
Fair Value
|
||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Structured notes
|
|
2
|
|
$
|
1,218
|
|
|
$
|
—
|
|
|
$
|
(1,054
|
)
|
|
$
|
164
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Structured notes
|
|
4
|
|
$
|
2,891
|
|
|
$
|
—
|
|
|
$
|
(2,713
|
)
|
|
$
|
178
|
|
|
|
|
|
|
|
|
|
Equity in (Losses) Earnings of Unconsolidated Entities
|
||||||||||
|
|
Ownership % at March 31, 2018
|
|
March 31,
2018 |
|
December 31,
2017 |
|
For the Three Months Ended March 31, 2018
|
|
For the Three Months Ended March 31, 2017
|
||||||||
|
|
|
|
|
|
|||||||||||||
|
Pelium Capital Partners, L.P.
(1)
|
80.2%
|
|
$
|
4,674
|
|
|
$
|
10,503
|
|
|
$
|
(305
|
)
|
|
$
|
(158
|
)
|
|
RCM Global, LLC
|
63.8%
|
|
217
|
|
|
—
|
|
|
13
|
|
|
(4
|
)
|
||||
|
Pearlmark Mezzanine Realty Partners IV, L.P.
(2)
|
—%
|
|
—
|
|
|
—
|
|
|
—
|
|
|
358
|
|
||||
|
Investment in LCC Preferred Stock
(3)
|
—%
|
|
—
|
|
|
—
|
|
|
—
|
|
|
165
|
|
||||
|
Subtotal
|
|
|
4,891
|
|
|
10,503
|
|
|
(292
|
)
|
|
361
|
|
||||
|
Investment in RCT I and II
(4)
|
3.0%
|
|
1,548
|
|
|
1,548
|
|
|
(724
|
)
|
|
(637
|
)
|
||||
|
Total
|
|
|
$
|
6,439
|
|
|
$
|
12,051
|
|
|
$
|
(1,016
|
)
|
|
$
|
(276
|
)
|
|
(1)
|
During the
three months ended
March 31, 2018
and
2017
, we received distributions of
$5.6 million
and
$13.6 million
, respectively, on our investment in Pelium Capital.
|
|
(2)
|
We sold our investment in Pearlmark Mezzanine Realty Partners IV, L.P. ("Pearlmark Mezz") in May 2017.
|
|
(3)
|
Our investment in LCC liquidated in July 2017 as a result of the sale of LCC.
|
|
(4)
|
For the
three months ended
March 31, 2018
and
2017
, distributions from the trusts are recorded in interest expense on our consolidated statements of operations as the investments are accounted for under the cost method.
|
|
|
|
Three Months Ended March 31, 2018
|
|
Year Ended December 31, 2017
|
||||||||||||||||||||||||
|
|
|
Commercial Real Estate Loans
|
|
Direct Financing Leases
|
|
Total
|
|
Commercial Real Estate Loans
|
|
Syndicated Corporate Loans
|
|
Direct Financing Leases
|
|
Total
|
||||||||||||||
|
Allowance for loan and lease losses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Allowance for loan and lease losses at beginning of period
|
|
$
|
5,328
|
|
|
$
|
735
|
|
|
$
|
6,063
|
|
|
$
|
3,829
|
|
|
$
|
—
|
|
|
$
|
465
|
|
|
$
|
4,294
|
|
|
Provision for (recovery of) loan and lease losses, net
|
|
(799
|
)
|
|
—
|
|
|
(799
|
)
|
|
1,499
|
|
|
3
|
|
|
270
|
|
|
1,772
|
|
|||||||
|
Loans charged-off
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
(3
|
)
|
|||||||
|
Allowance for loan and lease losses at end of period
|
|
$
|
4,529
|
|
|
$
|
735
|
|
|
$
|
5,264
|
|
|
$
|
5,328
|
|
|
$
|
—
|
|
|
$
|
735
|
|
|
$
|
6,063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||||||
|
|
|
Commercial Real Estate Loans
|
|
Direct Financing Leases
|
|
Total
|
|
Commercial Real Estate Loans
|
|
Syndicated Corporate Loans
|
|
Direct Financing Leases
|
|
Total
|
||||||||||||||
|
Allowance for loan and lease losses ending balance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Individually evaluated for impairment
|
|
$
|
2,500
|
|
|
$
|
—
|
|
|
$
|
2,500
|
|
|
$
|
2,500
|
|
|
$
|
—
|
|
|
$
|
735
|
|
|
$
|
3,235
|
|
|
Collectively evaluated for impairment
|
|
$
|
2,029
|
|
|
$
|
735
|
|
|
$
|
2,764
|
|
|
$
|
2,828
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,828
|
|
|
Loans acquired with deteriorated credit quality
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Loans and Leases:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Amortized cost ending balance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Individually evaluated for impairment
|
|
$
|
26,008
|
|
|
$
|
—
|
|
|
$
|
26,008
|
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
$
|
886
|
|
|
$
|
7,886
|
|
|
Collectively evaluated for impairment
|
|
$
|
1,355,520
|
|
|
$
|
824
|
|
|
$
|
1,356,344
|
|
|
$
|
1,283,150
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,283,150
|
|
|
Loans acquired with deteriorated credit quality
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
Risk Rating
|
|
Risk Characteristics
|
|
|
|
|
|
1
|
|
• Property performance has surpassed underwritten expectations.
|
|
|
|
• Occupancy is stabilized, the property has had a history of consistently high occupancy, and the property has a diverse and high quality tenant mix.
|
|
|
|
|
|
2
|
|
• Property performance is consistent with underwritten expectations and covenants and performance criteria are being met or exceeded.
|
|
|
|
• Occupancy is stabilized, near stabilized or is on track with underwriting.
|
|
|
|
|
|
3
|
|
• Property performance lags behind underwritten expectations.
|
|
|
|
• Occupancy is not stabilized and the property has some tenancy rollover
|
|
|
|
|
|
4
|
|
• Property performance significantly lags behind underwritten expectations. Performance criteria and loan covenants have required occasional waivers.
|
|
|
|
• Occupancy is not stabilized and the property has a large amount of tenancy rollover.
|
|
|
|
|
|
5
|
|
• Property performance is significantly worse than underwritten expectations. The loan is not in compliance with loan covenants and performance criteria and is in default. Expected sale proceeds would not be sufficient to pay off the loan at maturity.
|
|
|
|
• The property has material vacancy and significant rollover of remaining tenants.
|
|
|
|
• An updated appraisal is required.
|
|
|
Rating 1
|
|
Rating 2
|
|
Rating 3
|
|
Rating 4
|
|
Rating 5
|
|
Held for Sale
|
|
Total
|
||||||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Whole loans
(1)
|
$
|
52,010
|
|
|
$
|
1,179,981
|
|
|
$
|
118,688
|
|
|
$
|
4,841
|
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
$
|
1,362,520
|
|
|
Preferred equity investment
(2)
|
—
|
|
|
19,008
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,008
|
|
|||||||
|
Legacy CRE whole loans
(3)(4)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
63,882
|
|
|
63,882
|
|
|||||||
|
|
$
|
52,010
|
|
|
$
|
1,198,989
|
|
|
$
|
118,688
|
|
|
$
|
4,841
|
|
|
$
|
7,000
|
|
|
$
|
63,882
|
|
|
$
|
1,445,410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Whole loans
(1)
|
$
|
65,589
|
|
|
$
|
1,040,883
|
|
|
$
|
171,841
|
|
|
$
|
4,837
|
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
$
|
1,290,150
|
|
|
Legacy CRE whole loans
(3)(4)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
63,783
|
|
|
63,783
|
|
|||||||
|
|
$
|
65,589
|
|
|
$
|
1,040,883
|
|
|
$
|
171,841
|
|
|
$
|
4,837
|
|
|
$
|
7,000
|
|
|
$
|
63,783
|
|
|
$
|
1,353,933
|
|
|
(1)
|
Includes
one
CRE whole loan, with an amortized cost of
$7.0 million
, that was in default at
March 31, 2018
and
December 31, 2017
.
|
|
(2)
|
Our preferred equity investment is evaluated individually for impairment and excluded from the general reserve calculation.
|
|
(3)
|
Legacy CRE whole loans are carried at the lower of cost or fair value.
|
|
(4)
|
Includes
three
and
two
legacy CRE whole loans that were in default with total carrying values of
$40.5 million
and
$22.5 million
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
•
|
One
CRE whole loan collateralized by an office property in the Mountain region, as defined by the NCREIF, with an initial par value of
$17.7 million
. Upon transfer to held for sale in 2016, this loan was written down to its estimated fair value of
$11.0 million
, which remains the carrying value at
March 31, 2018
and
December 31, 2017
.
No
additional valuation adjustments were recognized for the
three months ended March 31, 2018
and
2017
. The loan matured in May 2017 and is currently in default;
|
|
•
|
One
CRE whole loan collateralized by a hotel in the Pacific region, as defined by the NCREIF, with an initial par value of
$29.5 million
. Upon transfer to held for sale in 2016, this loan was written down to its estimated fair value of
$24.0 million
. At
March 31, 2018
and
December 31, 2017
, the loan had a carrying value of
$18.0 million
and
$22.5 million
, respectively. An additional fair value adjustment of
$4.7 million
, which included protective advances of
$172,000
, to reduce the carrying value was recognized during the
three months ended March 31, 2018
. This adjustment was recorded based on the receipt of updated appraisals in April 2018 and was recognized in fair value adjustments on financial assets held for sale in our consolidated statements of operations.
No
valuation adjustments were recognized for the
three months ended March 31, 2017
. The loan has a maturity date in January 2019 and is currently in default.
|
|
|
30-59 Days
|
|
60-89 Days
|
|
Greater than 90 Days
|
|
Total Past Due
|
|
Current
|
|
Total Loans Receivable
(1)
|
|
Total Loans > 90 Days and Accruing
|
||||||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
(2)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
1,355,520
|
|
|
$
|
1,362,520
|
|
|
$
|
—
|
|
|
Preferred equity investment
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,008
|
|
|
19,008
|
|
|
—
|
|
|||||||
|
Legacy CRE whole loans
(3)
|
—
|
|
|
—
|
|
|
47,057
|
|
|
47,057
|
|
|
16,825
|
|
|
$
|
63,882
|
|
|
11,516
|
|
||||||
|
Total loans
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
54,057
|
|
|
$
|
54,057
|
|
|
$
|
1,391,353
|
|
|
$
|
1,445,410
|
|
|
$
|
11,516
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Whole loans
(2)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
1,283,150
|
|
|
$
|
1,290,150
|
|
|
$
|
—
|
|
|
Legacy CRE whole loans
(3)
|
11,516
|
|
|
—
|
|
|
11,000
|
|
|
22,516
|
|
|
41,267
|
|
|
63,783
|
|
|
—
|
|
|||||||
|
Total loans
|
$
|
11,516
|
|
|
$
|
—
|
|
|
$
|
18,000
|
|
|
$
|
29,516
|
|
|
$
|
1,324,417
|
|
|
$
|
1,353,933
|
|
|
$
|
—
|
|
|
(1)
|
Excludes direct financing leases of
$89,000
and
$151,000
, net of reserves, at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(2)
|
Includes
one
CRE whole loan, with an amortized cost of
$7.0 million
, that was in default at
March 31, 2018
and
December 31, 2017
.
|
|
(3)
|
Includes
three
and
two
legacy CRE whole loans that were in default with total carrying values of
$40.5 million
and
$22.5 million
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
|
Recorded Balance
|
|
Unpaid Principal Balance
|
|
Specific Allowance
|
|
Average Investment in Impaired Loans
|
|
Interest Income Recognized
|
||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Loans without a specific valuation allowance:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Loans with a specific valuation allowance:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Whole loans
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
(2,500
|
)
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
Total:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Whole loans
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
(2,500
|
)
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
At December 31, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Loans without a specific valuation allowance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Whole loans
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Loans with a specific valuation allowance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Whole loans
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
(2,500
|
)
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
Total:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Whole loans
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
(2,500
|
)
|
|
$
|
7,000
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2018 |
|
December 31,
2017 |
|
Net Change
|
||||||
|
Accrued interest receivable from loans
|
$
|
6,153
|
|
|
$
|
6,096
|
|
|
$
|
57
|
|
|
Accrued interest receivable from securities
|
785
|
|
|
756
|
|
|
29
|
|
|||
|
Accrued interest receivable from escrow and sweep accounts
|
7
|
|
|
7
|
|
|
—
|
|
|||
|
Total
|
$
|
6,945
|
|
|
$
|
6,859
|
|
|
$
|
86
|
|
|
|
March 31,
2018 |
|
December 31,
2017 |
|
Net Change
|
||||||
|
Tax receivables and prepaid taxes
|
$
|
3,211
|
|
|
$
|
4,286
|
|
|
$
|
(1,075
|
)
|
|
Management fees receivable
|
1,664
|
|
|
2,029
|
|
|
(365
|
)
|
|||
|
Other receivables
|
613
|
|
|
495
|
|
|
118
|
|
|||
|
Fixed assets - non real estate
|
144
|
|
|
157
|
|
|
(13
|
)
|
|||
|
Other
|
1,349
|
|
|
484
|
|
|
865
|
|
|||
|
Total
|
$
|
6,981
|
|
|
$
|
7,451
|
|
|
$
|
(470
|
)
|
|
CRE/Core Asset Class
|
|
Principal Investments
|
|
|
|
|
|
Commercial real estate-related assets
|
|
• First mortgage loans, which we refer to as whole loans;
|
|
|
|
• First priority interests in first mortgage loans, which we refer to as A notes;
|
|
|
|
• Subordinated interests in first mortgage loans, which we refer to as B notes;
|
|
|
|
• Mezzanine debt related to CRE that is senior to the borrower's equity position but subordinated to other third-party debt;
|
|
|
|
• Preferred equity investments related to CRE that are subordinate to first mortgage
loans and are not collateralized by the property underlying the investment;
|
|
|
|
• CMBS; and
|
|
|
|
• Other CRE investments.
|
|
|
||
|
In November 2016, we received approval from our Board to execute the Plan to focus our strategy on CRE debt investments. The Plan contemplates disposing of certain legacy CRE debt investments, exiting underperforming non-core asset classes and establishing a dividend policy based on sustainable earnings. Legacy CRE loans are loans underwritten prior to 2010. The non-core asset classes in which we have historically invested are described below:
|
||
|
|
||
|
Non-Core Asset Classes
|
|
Principal Investments
|
|
Residential real estate-related assets
|
|
• Residential mortgage loans; and
|
|
|
|
• Residential mortgage-backed securities, which we refer to as RMBS, which comprise our available-for-sale portfolio.
|
|
|
|
|
|
Commercial finance assets
|
|
• Middle market secured corporate loans and preferred equity investments;
|
|
|
|
• ABS, backed by senior secured corporate loans;
|
|
|
|
• Debt tranches of collateralized debt obligations, which we refer to as CDOs, and CLOs, respectively, and sometimes, collectively, as CDOs;
|
|
|
|
• Structured note investments, which comprise our trading securities portfolio;
|
|
|
|
• Syndicated corporate loans; and
|
|
|
|
• Preferred equity investment in a commercial leasing enterprise that originates and holds small- and middle-ticket commercial direct financing leases and notes.
|
|
At March 31, 2018
|
|
Amortized
Cost |
|
Net Carrying Amount
|
|
Percent of
Portfolio |
|
Weighted
Average Coupon |
|||||
|
Core Assets:
|
|
|
|
|
|
|
|
|
|||||
|
CRE whole loans
(1)(2)
|
|
$
|
1,362,520
|
|
|
$
|
1,357,991
|
|
|
80.23
|
%
|
|
6.34%
|
|
CRE preferred equity investment
(2)
|
|
19,008
|
|
|
19,008
|
|
|
1.12
|
%
|
|
11.50%
|
||
|
CMBS
(3)
|
|
251,343
|
|
|
250,746
|
|
|
14.81
|
%
|
|
4.36%
|
||
|
Total Core Assets
|
|
1,632,871
|
|
|
1,627,745
|
|
|
96.16
|
%
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Non-Core Assets:
|
|
|
|
|
|
|
|
|
|||||
|
Structured notes
(4)
|
|
1,218
|
|
|
164
|
|
|
0.01
|
%
|
|
N/A
(10)
|
||
|
Investments in unconsolidated entities
(5)
|
|
4,891
|
|
|
4,891
|
|
|
0.29
|
%
|
|
N/A
(10)
|
||
|
Direct financing leases
(6)
|
|
824
|
|
|
89
|
|
|
0.01
|
%
|
|
5.66%
|
||
|
Legacy CRE loans held for sale
(7)(8)
|
|
63,882
|
|
|
57,341
|
|
|
3.39
|
%
|
|
1.71%
|
||
|
Middle market loan held for sale
(7)(9)
|
|
13,837
|
|
|
1,978
|
|
|
0.12
|
%
|
|
—%
|
||
|
Life settlement contracts
(7)
|
|
177
|
|
|
177
|
|
|
0.01
|
%
|
|
N/A
(10)
|
||
|
Property available-for-sale
(7)
|
|
117
|
|
|
117
|
|
|
0.01
|
%
|
|
N/A
(10)
|
||
|
Total Non-Core Assets
|
|
84,946
|
|
|
64,757
|
|
|
3.84
|
%
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|||||
|
Total investment portfolio
|
|
$
|
1,717,817
|
|
|
$
|
1,692,502
|
|
|
100.00
|
%
|
|
|
|
(1)
|
Net carrying amount includes an allowance for loan losses of
$4.5 million
at
March 31, 2018
.
|
|
(2)
|
Classified as CRE loans on the consolidated balance sheets.
|
|
(3)
|
Classified as investment securities available-for-sale on the consolidated balance sheets.
|
|
(4)
|
Classified as investment securities, trading on the consolidated balance sheets.
|
|
(5)
|
Classified as investments in unconsolidated entities on the consolidated balance sheets.
|
|
(6)
|
Net carrying amount includes an allowance for lease losses of
$735,000
at
March 31, 2018
.
|
|
(7)
|
Classified as assets held for sale on the consolidated balance sheets.
|
|
(8)
|
Net carrying amount includes a lower of cost or market value adjustment of
$6.5 million
at
March 31, 2018
.
|
|
(9)
|
Net carrying amount includes the lower of cost or market value adjustment of
$11.9 million
at
March 31, 2018
.
|
|
(10)
|
There are no stated rates associated with these investments.
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
ASSETS
|
|
|
|
||||
|
Restricted cash
|
$
|
138
|
|
|
$
|
138
|
|
|
Accrued interest receivable
|
33
|
|
|
67
|
|
||
|
Loans held for sale
|
59,320
|
|
|
93,063
|
|
||
|
Property available-for-sale
|
117
|
|
|
—
|
|
||
|
Principal paydowns receivable
|
14,827
|
|
|
—
|
|
||
|
Other assets
(1)
|
3,186
|
|
|
14,450
|
|
||
|
Total assets held for sale
|
$
|
77,621
|
|
|
$
|
107,718
|
|
|
|
|
|
|
||||
|
LIABILITIES
|
|
|
|
||||
|
Accounts payable and other liabilities
|
$
|
2,883
|
|
|
$
|
10,283
|
|
|
Management fee payable
|
—
|
|
|
56
|
|
||
|
Accrued interest payable
|
—
|
|
|
3
|
|
||
|
Total liabilities held for sale
|
$
|
2,883
|
|
|
$
|
10,342
|
|
|
(1)
|
Includes our investment in life settlement contracts of
$177,000
and
$5.1 million
at
March 31, 2018
and
December 31, 2017
, respectively, which were transferred to held for sale in the fourth quarter of 2016.
|
|
|
Asset Derivatives
|
||||||||
|
|
Notional Amount
|
|
Consolidated Balance Sheets Location
|
|
Fair Value
|
||||
|
Interest rate swap contracts, hedging
(1)
|
$
|
44,570
|
|
|
Derivatives, at fair value
|
|
$
|
1,751
|
|
|
|
|
|
|
|
|
||||
|
|
Liability Derivatives
|
||||||||
|
|
Notional Amount
|
|
Consolidated Balance Sheets Location
|
|
Fair Value
|
||||
|
Interest rate swap contracts, hedging
|
$
|
44,570
|
|
|
Accumulated other comprehensive income
|
|
$
|
1,751
|
|
|
(1)
|
Interest rate swap contracts are accounted for as cash flow hedges.
|
|
|
Asset Derivatives
|
||||||||
|
|
Notional Amount
|
|
Consolidated Balance Sheets Location
|
|
Fair Value
|
||||
|
Interest rate swap contracts, hedging
(1)
|
$
|
41,750
|
|
|
Derivatives, at fair value
|
|
$
|
602
|
|
|
|
|
|
|
|
|
||||
|
|
Liability Derivatives
|
||||||||
|
|
Notional Amount
|
|
Consolidated Balance Sheets Location
|
|
Fair Value
|
||||
|
Forward contracts - foreign currency, hedging
(2)(3)
|
$
|
3,602
|
|
|
Derivatives, at fair value
|
|
$
|
76
|
|
|
Interest rate swap contracts, hedging
|
$
|
41,750
|
|
|
Accumulated other comprehensive income
|
|
$
|
602
|
|
|
(1)
|
Interest rate swap contracts are accounted for as cash flow hedges.
|
|
(2)
|
Foreign currency forward contracts are accounted for as fair value hedges.
|
|
(3)
|
Notional amount is presented on a currency converted basis. The base currency notional amount of our foreign currency hedging forward contracts in a liability position was
€3.0 million
at
December 31, 2017
.
|
|
|
|
Derivatives
|
||||
|
|
|
Consolidated Statements of Operations Location
|
|
Realized and Unrealized Gain (Loss)
(1)
|
||
|
Interest rate swap contracts, hedging
|
|
Interest expense
|
|
$
|
(50
|
)
|
|
(1)
|
Negative values indicate a decrease to the associated consolidated statements of operations line items.
|
|
|
|
Derivatives
|
||||
|
|
|
Consolidated Statements of Operations Location
|
|
Realized and Unrealized Gain (Loss)
(1)
|
||
|
Interest rate swap contracts, hedging
|
|
Interest expense
|
|
$
|
(18
|
)
|
|
Forward contracts - foreign currency, hedging
|
|
Net realized and unrealized (loss) gain on investment securities available-for-sale and loans and derivatives
|
|
$
|
(195
|
)
|
|
(1)
|
Negative values indicate a decrease to the associated consolidated statements of operations line items.
|
|
|
|
Benchmark Rate
|
|
Notional Value
|
|
Strike Rate
|
|
Effective Date
|
|
Maturity Date
|
|
Fair Value
|
||||
|
CMBS repurchase facilities swaps:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Interest rate swap
|
|
One-month LIBOR
|
|
$
|
7,500
|
|
|
1.99%
|
|
6/18/2017
|
|
10/18/2025
|
|
$
|
321
|
|
|
Interest rate swap
|
|
One-month LIBOR
|
|
3,010
|
|
|
2.02%
|
|
6/18/2017
|
|
1/28/2026
|
|
125
|
|
||
|
Interest rate swap
|
|
One-month LIBOR
|
|
2,525
|
|
|
1.94%
|
|
7/18/2017
|
|
10/18/2025
|
|
116
|
|
||
|
Interest rate swap
|
|
One-month LIBOR
|
|
3,640
|
|
|
2.15%
|
|
8/18/2017
|
|
3/18/2027
|
|
143
|
|
||
|
Interest rate swap
|
|
One-month LIBOR
|
|
4,025
|
|
|
2.09%
|
|
8/18/2017
|
|
10/18/2026
|
|
165
|
|
||
|
Interest rate swap
|
|
One-month LIBOR
|
|
13,550
|
|
|
2.09%
|
|
10/18/2017
|
|
9/18/2027
|
|
631
|
|
||
|
Interest rate swap
|
|
One-month LIBOR
|
|
7,500
|
|
|
2.20%
|
|
10/18/2017
|
|
9/18/2027
|
|
281
|
|
||
|
Interest rate swap
|
|
One-month LIBOR
|
|
2,820
|
|
|
2.77%
|
|
3/18/2018
|
|
3/18/2028
|
|
(31
|
)
|
||
|
Total CMBS repurchase facilities swaps
|
|
|
|
$
|
44,570
|
|
|
|
|
|
|
|
|
$
|
1,751
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
|
|
Outstanding Borrowings
(1)
|
|
Value of Collateral
|
|
Number of Positions as Collateral
|
|
Weighted Average Interest Rate
|
|
Outstanding Borrowings
(1)
|
|
Value of Collateral
|
|
Number of Positions as Collateral
|
|
Weighted Average Interest Rate
|
||||||||
|
CRE - Term Repurchase Facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Wells Fargo Bank, N.A.
(2)
|
$
|
258,160
|
|
|
$
|
376,843
|
|
|
23
|
|
3.92%
|
|
$
|
179,347
|
|
|
$
|
268,003
|
|
|
19
|
|
3.68%
|
|
Morgan Stanley Bank, N.A.
(3)
|
172,225
|
|
|
245,361
|
|
|
12
|
|
4.36%
|
|
112,151
|
|
|
164,122
|
|
|
9
|
|
4.05%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
CMBS - Term Repurchase Facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Wells Fargo Bank, N.A.
|
—
|
|
|
—
|
|
|
—
|
|
—%
|
|
12,272
|
|
|
14,984
|
|
|
8
|
|
2.45%
|
||||
|
Deutsche Bank AG
|
13,532
|
|
|
20,372
|
|
|
14
|
|
3.99%
|
|
15,356
|
|
|
23,076
|
|
|
14
|
|
3.53%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Trust Certificates - Term Repurchase Facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
RSO Repo SPE Trust 2015
(4)
|
26,583
|
|
|
89,121
|
|
|
2
|
|
7.29%
|
|
26,548
|
|
|
89,121
|
|
|
2
|
|
6.98%
|
||||
|
RSO Repo SPE Trust 2017
(5)
|
47,048
|
|
|
118,780
|
|
|
2
|
|
5.74%
|
|
49,596
|
|
|
125,254
|
|
|
2
|
|
5.43%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
CMBS - Short-Term Repurchase Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
RBC Capital Markets, LLC
|
125,369
|
|
|
173,574
|
|
|
15
|
|
3.11%
|
|
72,131
|
|
|
97,745
|
|
|
6
|
|
2.77%
|
||||
|
JP Morgan Securities LLC
|
10,529
|
|
|
33,709
|
|
|
2
|
|
3.41%
|
|
10,516
|
|
|
33,777
|
|
|
2
|
|
2.93%
|
||||
|
Total
|
$
|
653,446
|
|
|
$
|
1,057,760
|
|
|
|
|
|
|
$
|
477,917
|
|
|
$
|
816,082
|
|
|
|
|
|
|
(1)
|
Outstanding borrowings includes
accrued interest payable
.
|
|
(2)
|
Includes
$313,000
and
$565,000
of deferred debt issuance costs at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(3)
|
Includes
$289,000
and
$448,000
of deferred debt issuance costs at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(4)
|
Includes
$96,000
and
$133,000
of deferred debt issuance costs at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(5)
|
Includes
$292,000
and
$320,000
of deferred debt issuance costs at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
|
|
Total Amount
|
|
Per Share Amount
|
||||
|
Common stock book value at December 31, 2017
(1)
|
|
$
|
447,634
|
|
|
$
|
14.46
|
|
|
Net loss allocable to common shares
|
|
(12,582
|
)
|
|
(0.40
|
)
|
||
|
Change in other comprehensive income:
|
|
|
|
|
||||
|
Available-for-sale securities
|
|
(1,292
|
)
|
|
(0.04
|
)
|
||
|
Derivatives
|
|
1,149
|
|
|
0.03
|
|
||
|
Common stock dividends
|
|
(1,560
|
)
|
|
(0.05
|
)
|
||
|
Common stock dividends on unvested shares
|
|
(23
|
)
|
|
—
|
|
||
|
Accretion (dilution) from additional shares outstanding at March 31, 2018
(2)
|
|
898
|
|
|
(0.08
|
)
|
||
|
Total net decrease
|
|
(13,410
|
)
|
|
(0.54
|
)
|
||
|
Common stock book value at March 31, 2018
(1)(3)
|
|
$
|
434,224
|
|
|
$
|
13.92
|
|
|
(1)
|
Per share calculations exclude unvested restricted stock, as disclosed on our consolidated balance sheets, of
465,808
shares and
483,073
shares at
March 31, 2018
and
December 31, 2017
, respectively. The denominator for the calculation is
31,184,609
and
30,946,819
at
March 31, 2018
and
December 31, 2017
, respectively.
|
|
(2)
|
Per share amount calculation includes the impact of
237,790
additional shares.
|
|
(3)
|
Common stock book value is calculated as total stockholders' equity of
$550.2 million
less preferred stock equity of
$116.0 million
at
March 31, 2018
.
|
|
|
For the Three Months Ended
|
||||||||||||||
|
|
March 31,
|
||||||||||||||
|
|
2018
|
|
Per Share Data
|
|
2017
|
|
Per Share Data
|
||||||||
|
Net (loss) income allocable to common shares - GAAP
|
$
|
(12,582
|
)
|
|
$
|
(0.40
|
)
|
|
$
|
2,700
|
|
|
$
|
0.09
|
|
|
Adjustment for realized gain on CRE assets
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Net (loss) income allocable to common shares - GAAP, adjusted
|
(12,582
|
)
|
|
(0.40
|
)
|
|
2,700
|
|
|
0.09
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Reconciling items from continuing operations:
|
|
|
|
|
|
|
|
||||||||
|
Non-cash equity compensation expense
|
967
|
|
|
0.03
|
|
|
788
|
|
|
0.02
|
|
||||
|
Non-cash (recovery of) provision for CRE loan losses
|
(799
|
)
|
|
(0.03
|
)
|
|
860
|
|
|
0.03
|
|
||||
|
Realized loss on core activities
(4)
|
(2,167
|
)
|
|
(0.07
|
)
|
|
—
|
|
|
—
|
|
||||
|
Non-cash amortization of discounts or premiums associated with borrowings
|
778
|
|
|
0.02
|
|
|
414
|
|
|
0.01
|
|
||||
|
Net income from limited partnership interest owned at the initial measurement date
(1)
|
—
|
|
|
—
|
|
|
(358
|
)
|
|
(0.01
|
)
|
||||
|
Income tax (benefit) expense from non-core investments
(2)(3)
|
(32
|
)
|
|
—
|
|
|
1,499
|
|
|
0.05
|
|
||||
|
Net realized loss on non-core assets
(2)(3)
|
215
|
|
|
0.01
|
|
|
—
|
|
|
—
|
|
||||
|
Net loss (income) from non-core assets
(3)
|
397
|
|
|
0.01
|
|
|
(1,429
|
)
|
|
(0.05
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Reconciling items from discontinued operations and CRE assets:
|
|
|
|
|
|
|
|
||||||||
|
Net interest income on legacy CRE loans held for sale
|
(322
|
)
|
|
(0.01
|
)
|
|
(1,324
|
)
|
|
(0.04
|
)
|
||||
|
Realized gain on liquidation of CRE loans
|
—
|
|
|
—
|
|
|
(6,954
|
)
|
|
(0.23
|
)
|
||||
|
Fair value adjustments on legacy CRE loans held for sale
|
4,672
|
|
|
0.15
|
|
|
—
|
|
|
—
|
|
||||
|
Net loss (income) from other non-CRE investments held for sale
|
478
|
|
|
0.02
|
|
|
(25
|
)
|
|
—
|
|
||||
|
(Income) loss from discontinued operations, net of taxes
|
(247
|
)
|
|
(0.01
|
)
|
|
561
|
|
|
0.02
|
|
||||
|
Core Earnings allocable to common shares
(5)
|
$
|
(8,642
|
)
|
|
$
|
(0.28
|
)
|
|
$
|
(3,268
|
)
|
|
$
|
(0.11
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Reconciling items for nonrecurring activities:
|
|
|
|
|
|
|
|
||||||||
|
Loss on redemption of Series B Preferred Stock
|
7,482
|
|
|
0.24
|
|
|
—
|
|
|
—
|
|
||||
|
Realized loss on core activities
|
2,167
|
|
|
0.07
|
|
|
—
|
|
|
—
|
|
||||
|
Core Earnings allocable to common shares, adjusted
|
$
|
1,007
|
|
|
$
|
0.03
|
|
|
$
|
(3,268
|
)
|
|
$
|
(0.11
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted average common shares - diluted
|
31,111
|
|
|
|
|
30,752
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Core Earnings per common share - diluted
(5)
|
$
|
(0.28
|
)
|
|
|
|
$
|
(0.11
|
)
|
|
|
||||
|
Core Earnings per common share, adjusted - diluted
|
$
|
0.03
|
|
|
|
|
$
|
(0.11
|
)
|
|
|
||||
|
(1)
|
Initial measurement date is December 31, 2016.
|
|
(2)
|
Income tax (benefit) expense from non-core investments and net realized loss on non-core assets are components of net income or loss from non-core assets.
|
|
(3)
|
Non-core assets are investments and securities owned by RSO at the initial measurement date in (i) commercial finance, (ii) middle market lending, (iii) residential mortgage lending, (iv) legacy CRE loans designated as held for sale and (v) other non-CRE assets included in assets held for sale.
|
|
(4)
|
Payment of pending settlement of a securities litigation, previously accrued in
2017
.
|
|
(5)
|
Core Earnings include a non-recurring charge of
$7.5 million
, or
$(0.24)
per common share-diluted, in connection with the redemption of Series B Preferred Stock.
|
|
|
Identified Assets at Plan Inception
|
|
Impairments/Adjustments on Non-Monetized Assets
(1)(2)
|
|
Impairments/Adjustments on Monetized Assets
(1)
|
|
Monetized through March 31, 2018
(3)
|
|
Net Book Value at March 31, 2018
(3)
|
||||||||||
|
Discontinued operations and assets held for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Legacy CRE loans
(4)
|
$
|
194.7
|
|
|
$
|
(18.3
|
)
|
|
$
|
(11.7
|
)
|
|
$
|
(107.4
|
)
|
|
$
|
57.3
|
|
|
Middle market loans
|
73.8
|
|
|
(17.0
|
)
|
|
(0.8
|
)
|
|
(54.0
|
)
|
|
2.0
|
|
|||||
|
Residential mortgage lending segment
(5)
|
56.6
|
|
|
(1.7
|
)
|
|
(9.6
|
)
|
|
(43.7
|
)
|
|
1.6
|
|
|||||
|
Other assets held for sale
|
5.9
|
|
|
—
|
|
|
3.9
|
|
|
(8.9
|
)
|
|
0.9
|
|
|||||
|
Subtotal - discontinued operations and assets held for sale
|
$
|
331.0
|
|
|
$
|
(37.0
|
)
|
|
$
|
(18.2
|
)
|
|
$
|
(214.0
|
)
|
|
$
|
61.8
|
|
|
Investments in unconsolidated entities
|
86.6
|
|
|
—
|
|
|
38.3
|
|
|
(124.3
|
)
|
|
0.6
|
|
|||||
|
Commercial finance assets
|
62.5
|
|
|
—
|
|
|
—
|
|
|
(62.3
|
)
|
|
0.2
|
|
|||||
|
Total
|
$
|
480.1
|
|
|
$
|
(37.0
|
)
|
|
$
|
20.1
|
|
|
$
|
(400.6
|
)
|
|
$
|
62.6
|
|
|
(1)
|
Reflects adjustments as a result of the designation as assets held for sale or discontinued operations, which occurred during the third and fourth quarters of 2016 except as noted in (2) below.
|
|
(2)
|
The impairment adjustment to middle market loans includes
$5.4 million
of fair value adjustments that occurred prior to the inception of the Plan.
|
|
(3)
|
Residential mortgage lending segment and investments in unconsolidated entities include pro forma adjustments of
$3.6 million
and
$4.3 million
, respectively, for proceeds received in April 2018. Middle market loans include pro forma adjustments of
$14.8 million
for proceeds received in May 2018.
|
|
(4)
|
Legacy CRE loans includes
$118.2 million
par value of loans at the inception of the Plan that were not reflected on the consolidated balance sheets until our investment in RREF CDO 2007-1 was liquidated in November 2016.
|
|
(5)
|
Includes
$1.9 million
of cash and cash equivalents not classified as assets held for sale in the residential mortgage lending segment at
March 31, 2018
.
|
|
1.
|
Repurchase Agreements:
Repurchase agreements effectively allow us to borrow against loans and securities that we own. Under these agreements, we sell our loans and securities to a counterparty and agree to repurchase the same loans and securities from the counterparty at a price equal to the original sales price plus interest. The counterparty retains the sole discretion over both whether to purchase the loan and security from us and, subject to certain conditions, the market value of such loan or security for purposes of determining whether we are required to pay margin to the counterparty. Generally, if the lender determines (subject to certain conditions) that the market value of the collateral in a repurchase transaction has decreased by more than a defined minimum amount, we would be required to repay any amounts borrowed in excess of the product of (i) the revised market value multiplied by (ii) the applicable advance rate. During the term of a repurchase agreement, we receive the principal and interest on the related loans and securities and pay interest to the counterparty. As of March 31, 2018, we have various repurchase agreements, as described below.
|
|
2.
|
Loan Sales, Syndications and Securitizations:
We seek non‑recourse long‑term financing from loan sales, syndications and/or securitizations of our investments in CRE loans. The sales, syndications or securitizations generally involve a senior portion of our loan, but may involve the entire loan. Loan sales and syndications generally involve the sale of a senior note component or participation interest to a third party lender. Securitization generally involves transferring notes to a special purpose vehicle (or the issuing entity), which then issues one or more classes of non‑recourse notes pursuant to the terms of an indenture. The notes are secured by the pool of assets. In exchange for the transfer of assets to the issuing entity, we receive cash proceeds from the sale of non‑recourse notes. Sales, syndications or securitizations of our portfolio investments might magnify our exposure to losses on those portfolio investments because the retained subordinate interest in any particular overall loan would be subordinate to the loan components sold and we would, therefore, absorb all losses sustained with respect to the overall loan before the owners of the senior notes experience any losses with respect to the loan in question.
|
|
Name
|
|
Cash Distributions
|
|
Overcollateralization Cushion
(1)
|
|
End of Designated Principal Reinvestment Period
|
||||||||||||
|
|
For the Three Months Ended March 31, 2018
|
|
For the Year Ended December 31, 2017
|
|
At March 31, 2018
|
|
At the Initial Measurement Date
|
|
||||||||||
|
RCC 2015-CRE3
(2)
|
|
$
|
1,428
|
|
|
$
|
8,672
|
|
|
$
|
61,469
|
|
|
$
|
20,313
|
|
|
February 2017
|
|
RCC 2015-CRE4
(2)
|
|
$
|
1,887
|
|
|
$
|
8,554
|
|
|
$
|
72,184
|
|
|
$
|
9,397
|
|
|
September 2017
|
|
RCC 2017-CRE5
(2)
|
|
$
|
10,601
|
|
|
$
|
6,643
|
|
|
$
|
19,655
|
|
|
$
|
20,727
|
|
|
July 2020
|
|
Apidos Cinco
(3)
|
|
$
|
—
|
|
|
$
|
2,056
|
|
|
N/A
|
|
|
$
|
17,774
|
|
|
N/A
|
|
|
(1)
|
Overcollateralization cushion represents the amount by which the collateral held by the securitization issuer exceeds the maximum amount required.
|
|
(2)
|
The designated principal reinvestment period for RCC 2015-CRE3, RCC 2015-CRE4 and RCC 2017-CRE5 is the period in which principal repayments can be utilized to purchase loans held outside of the respective securitization that represent the funded commitments of existing collateral in the respective securitization that were not funded as of the date the respective securitization was closed. Additionally, the indenture for each securitization does not contain any interest coverage test provisions.
|
|
(3)
|
Apidos Cinco was substantially liquidated in November 2016.
|
|
Name
|
|
Cash Distributions
|
|
Liquidation Details
|
||||||||||
|
|
For the Three Months Ended March 31, 2018
|
|
For the Year Ended December 31, 2017
|
|
Liquidation Date
|
|
Remaining Assets at the Liquidation Date
(1)
|
|||||||
|
|
|
|
|
|||||||||||
|
RCC 2014-CRE2
(2)
|
|
$
|
—
|
|
|
$
|
33,050
|
|
|
August 2017
|
|
$
|
92,980
|
|
|
(1)
|
The remaining assets at the liquidation date were measured at fair value and returned to us in exchange for our preference share and equity notes in the respective securitization.
|
|
(2)
|
Cash distributions for the
year ended December 31, 2017
includes preference share and equity notes distributions at liquidation of
$25.6 million
for RCC 2014-CRE2.
|
|
•
|
unrestricted cash and cash equivalents of
$67.1 million
;
|
|
•
|
approximately $87.0 million of available liquidity from the financing of unlevered CRE and CMBS positions; and
|
|
•
|
$396.2 million
available under
three
term financing facilities to finance CRE loans.
|
|
|
|
Contractual Commitments
(1)
|
||||||||||||||||||
|
|
|
(dollars in thousands, except amounts in footnotes)
|
||||||||||||||||||
|
|
|
Payments due by Period
|
||||||||||||||||||
|
|
|
Total
|
|
Less than 1 Year
|
|
1 - 3 Years
|
|
3 - 5 Years
|
|
More than 5 Years
|
||||||||||
|
At March 31, 2018:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
CRE securitizations
|
|
$
|
298,971
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
$
|
298,971
|
|
|
|
Unsecured junior subordinated debentures
(2)
|
|
51,548
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
51,548
|
|
|||||
|
4.50% Convertible Senior Notes
(3)
|
|
127,872
|
|
|
—
|
|
|
—
|
|
|
127,872
|
|
|
—
|
|
|||||
|
6.00% Convertible Senior Notes
(4)
|
|
69,776
|
|
|
69,776
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
8.00% Convertible Senior Notes
(5)
|
|
20,773
|
|
|
—
|
|
|
20,773
|
|
|
—
|
|
|
—
|
|
|||||
|
Repurchase and credit facilities
(6)
|
|
653,446
|
|
|
606,398
|
|
|
47,048
|
|
|
—
|
|
|
—
|
|
|||||
|
Unfunded commitments on CRE loans
(7)
|
|
86,157
|
|
|
22,916
|
|
|
63,241
|
|
|
—
|
|
|
—
|
|
|||||
|
Base management fees
(8)
|
|
10,517
|
|
|
10,517
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total
|
|
$
|
1,319,060
|
|
|
$
|
709,607
|
|
|
$
|
131,062
|
|
|
$
|
127,872
|
|
|
$
|
350,519
|
|
|
(1)
|
Contractual commitments on borrowings are presented net of deferred debt issuance costs and discounts.
|
|
(2)
|
Contractual commitments exclude
$33.2 million
and
$33.7 million
of estimated interest expense payable through maturity, in
June 2036
and
October 2036
, respectively, on our trust preferred securities.
|
|
(3)
|
Contractual commitments exclude
$28.7 million
of interest expense payable through maturity, in
August 2022
, on our 4.50% convertible senior notes due 2022.
|
|
(4)
|
Contractual commitments exclude
$2.9 million
of interest expense payable through maturity, in
December 2018
, on our 6.00% convertible senior notes due 2018.
|
|
(5)
|
Contractual commitments exclude
$3.1 million
of interest expense payable through maturity, in
January 2020
, on our 8.00% convertible senior notes due 2020.
|
|
(6)
|
Contractual commitments include
$1.4 million
of
accrued interest payable
at
March 31, 2018
on our repurchase facilities.
|
|
(7)
|
Unfunded commitments on our originated CRE whole loans generally fall into two categories: (i) pre-approved capital improvement projects and (ii) new or additional construction costs subject, in each case, to the borrower meeting specified criteria. Upon completion of the improvements or construction, we would receive additional interest income on the advanced amount. At
March 31, 2018
, we had unfunded commitments on
43
CRE whole loans.
|
|
(8)
|
Base management fees presented are based on an estimate of base management fees payable to our manager over the next the next 12 months. Our management agreement also provides for an incentive fee arrangement that is based on operating performance. Because the incentive fee is not a fixed and determinable amount, it is not included in this table.
|
|
ITEM 3 .
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
|
|
March 31, 2018
|
||||||||||
|
|
Interest rates fall 100
basis points |
|
Unchanged
|
|
Interest rates rise 100
basis points |
||||||
|
Interest rate-sensitive investment securities:
|
|
|
|
|
|
||||||
|
Fair value
|
$
|
96,940
|
|
|
$
|
94,093
|
|
|
$
|
92,132
|
|
|
Change in fair value
|
$
|
2,847
|
|
|
$
|
—
|
|
|
$
|
(1,961
|
)
|
|
Change as a percent of fair value
|
3.03
|
%
|
|
—
|
%
|
|
(2.08
|
)%
|
|||
|
|
|
|
|
|
|
||||||
|
Interest rate-sensitive hedging instruments:
|
|
|
|
|
|
|
|
|
|||
|
Fair value
|
$
|
(1,828
|
)
|
|
$
|
1,751
|
|
|
$
|
5,162
|
|
|
Change in fair value
|
$
|
(3,579
|
)
|
|
$
|
—
|
|
|
$
|
3,411
|
|
|
Change as a percent of fair value
|
(204
|
)%
|
|
|
|
|
195
|
%
|
|||
|
•
|
monitoring and adjusting, if necessary, the reset index and interest rate related to our borrowings;
|
|
•
|
attempting to structure our borrowing agreements for our CMBS to have a range of different maturities, terms, amortizations and interest rate adjustment periods; and
|
|
•
|
using derivatives to adjust the interest rate sensitivity of our variable-rate borrowings, which we discuss in "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - Financial Condition - Hedging Instruments."
|
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
|
ITEM 1A.
|
RISK FACTORS
|
|
ITEM 6.
|
EXHIBITS
|
|
Exhibit No.
|
|
Description
|
|
2.1
|
|
|
|
3.1(a)
|
|
|
|
3.1(b)
|
|
|
|
3.1(c)
|
|
|
|
3.1(d)
|
|
|
|
3.1(e)
|
|
|
|
3.1(f)
|
|
|
|
3.1(g)
|
|
|
|
3.2
|
|
|
|
4.1(a)
|
|
|
|
4.1(b)
|
|
|
|
4.1(c)
|
|
|
|
4.1(d)
|
|
|
|
4.2(a)
|
|
|
|
4.2(b)
|
|
|
|
4.3(a)
|
|
|
|
4.3(b)
|
|
|
|
4.4
|
|
|
|
4.5(a)
|
|
|
|
4.5(b)
|
|
|
|
4.6(a)
|
|
|
|
4.6(b)
|
|
|
|
4.7
|
|
|
|
4.8(a)
|
|
|
|
4.8(b)
|
|
|
|
4.8(c)
|
|
|
|
4.8(d)
|
|
|
|
4.8(e)
|
|
|
|
4.8(f)
|
|
|
|
4.8(g)
|
|
|
|
10.1
|
|
|
|
10.2(a)
|
|
|
|
10.2(b)
|
|
|
|
10.2(c)
|
|
|
|
10.3(a)
|
|
|
|
10.3(b)
|
|
|
|
10.3(c)
|
|
|
|
10.4
|
|
|
|
10.5
|
|
|
|
10.6
|
|
|
|
10.7
|
|
|
|
10.8
|
|
|
|
10.9
|
|
|
|
12.1
|
|
|
|
31.1
|
|
|
|
31.2
|
|
|
|
32.1
|
|
|
|
32.2
|
|
|
|
99.1(a)
|
|
|
|
99.1(b)
|
|
|
|
99.1(c)
|
|
|
|
99.1(d)
|
|
|
|
99.3(a)
|
|
|
|
99.3(b)
|
|
|
|
99.4(a)
|
|
|
|
99.4(b)
|
|
|
|
99.6
|
|
|
|
99.7
|
|
|
|
101
|
|
Interactive Data Files.
|
|
(1)
|
|
Filed previously as an exhibit to the Company's registration statement on Form S-11, Registration No. 333-126517.
|
|
(2)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2006.
|
|
(3)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2006.
|
|
(4)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2013.
|
|
(5)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on June 26, 2014.
|
|
(6)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2009.
|
|
(7)
|
|
Filed previously as an exhibit to the Company's Proxy Statement filed on April 16, 2014.
|
|
(8)
|
|
Filed previously as an exhibit to the Company's Registration Statement on Form S-11 (File No. 333-132836).
|
|
(9)
|
|
Filed previously as an exhibit to the Company's Registration Statement on Form 8-A filed on June 9, 2014.
|
|
(10)
|
|
Filed previously as an exhibit to the Company's Annual Report on Form 10-K for the year ended December 31, 2010.
|
|
(11)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on March 2, 2011.
|
|
(12)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on February 4, 2014.
|
|
(13)
|
|
Filed previously as an exhibit to the Company's Annual Report on Form 10-K for the year ended December 31, 2012 filed on March 18, 2013.
|
|
(14)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on March 2, 2012.
|
|
(15)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on June 13, 2012.
|
|
(16)
|
|
Filed previously as an exhibit to the Company's registration statement on Form 8-A filed on June 8, 2012.
|
|
(17)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on June 29, 2012.
|
|
(18)
|
|
Filed previously as an exhibit to the Company's Registration Statement on Form 8-A filed on September 28, 2012.
|
|
(19)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on September 23, 2014.
|
|
(20)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on January 13, 2015.
|
|
(21)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on October 1, 2012.
|
|
(22)
|
|
Filed previously as an exhibit to the Company Current Report on Form 8-K filed on November 20, 2012.
|
|
(23)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on April 8, 2013.
|
|
(24)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on July 25, 2013.
|
|
(25)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on October 21, 2013.
|
|
(26)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on November 20, 2014.
|
|
(27)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014.
|
|
(28)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.
|
|
(29)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on September 1, 2015.
|
|
(30)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on September 16, 2015.
|
|
(31)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2016.
|
|
(32)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on August 5, 2016.
|
|
(33)
|
|
Filed previously as an exhibit to the Company's Annual Report on Form 10-K for the year ended December 31, 2016.
|
|
(34)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on June 8, 2017.
|
|
(35)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2017.
|
|
(36)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on August 16, 2017.
|
|
(37)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2016.
|
|
(38)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on December 18, 2017.
|
|
(39)
|
|
Filed previously as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2017.
|
|
(40)
|
|
Filed previously as an exhibit to the Company's Current Report on Form 8-K filed on April 12, 2018.
|
|
|
|
|
RESOURCE CAPITAL CORP.
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
May 9, 2018
|
|
By:
|
/s/ Robert C. Lieber
|
|
|
|
|
Robert C. Lieber
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
May 9, 2018
|
|
By:
|
/s/ David J. Bryant
|
|
|
|
|
David J. Bryant
|
|
|
|
|
Senior Vice President
|
|
|
|
|
Chief Financial Officer and Treasurer
|
|
|
|
|
|
|
May 9, 2018
|
|
By:
|
/s/ Eldron C. Blackwell
|
|
|
|
|
Eldron C. Blackwell
|
|
|
|
|
Vice President
|
|
|
|
|
Chief Accounting Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|